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In the early mouse embryo and in embryonic stem cell (ESC) cultures the 
transcription factor Myc exhibits a cell-to-cell heterogeneous pattern. Cells 
expressing low levels of Myc are eliminated from the population by cell competition. 
Myc has been reported to promote cell reprograming to pluripotency and to regulate 
cell anabolism and proliferation in ESCs; however, the biological role of Myc-
dependent endogenous cell competition and the dynamics and regulation of Myc 
during this process remain unknown. 
 
Here we develop a new image analysis tool that allows us to track the temporal 
evolution of endogenous Myc levels, perform neighbourhood analysis in ESC cultures 
and generate 3D+t computerized data. We show that despite Myc degradation and 
resynthesis during mitosis, Myc levels are mostly heritable in ESC lineages. Cell 
competition results from random interactions between cells with high discrepancies 
in Myc levels. Myc-low cells (“losers”) temporally integrate contacts with Myc-high 
cells (“winners”), which leads to a progressive decrease in their own Myc levels until 
dying. Interestingly, endogenous Myc levels correlate with the pluripotency status; 
differentiation-primed cells express low Myc levels and are outcompeted by Myc-high 
naive ESCs. Indeed, cell competition inhibition results in an accumulation of primed 
cells. These observations in ESCs correlate with findings in the mouse epiblast. 
Moreover, we show that Myc levels directly determine the competitive ability of ESCs 
irrespective of the pluripotency status. 
 
Our results identify Myc as a mediator between differentiation status and 
competitive ability of pluripotent cells. Myc-driven endogenous cell competition thus 













Tanto en el embrión temprano de ratón como en cultivos de células madre 
embrionarias (CMEs), el factor de transcripción Myc muestra un patrón de expresión 
heterogéneo. Las células que expresan menos niveles de Myc son eliminadas de la 
población mediante competición celular. Se ha demostrado que Myc promueve la 
programación celular hacia un estado de pluripotencia y regula el anabolismo y la 
proliferación en CMEs; sin embargo, la función biológica de la competición celular 
endógena dependiente de Myc, así como la regulación y dinámica de la expresión este 
gen durante este proceso aún se desconocen.  
 
En esta tesis desarrollamos una novedosa herramienta de análisis de imagen, a 
partir de la cual realizamos análisis de células individuales y sus vecindarios y 
generamos un sistema de datos 3D+t computarizados. De esta manera demostramos 
que, a pesar de que Myc se degrada y se vuelve a sintetizar rápidamente durante la 
mitosis, sus niveles de expresión son en su mayor parte heredables. Además, la 
competición celular se desencadena por interacciones aleatorias entre células con 
grandes diferencias en sus niveles de Myc; de forma que las células que poseen bajos 
niveles de Myc (“perdedoras”) integran en el tiempo contactos con células con mayor 
expresión (“ganadoras”) lo que lleva a una reducción progresiva en sus propios 
niveles hasta que mueren. Cabe resaltar que los niveles endógenos de Myc 
correlacionan con el estado de pluripotencia; las células en un estado más avanzado 
de diferenciación expresan menos Myc siendo eliminadas por células más 
indiferenciadas y con altos niveles de expresión. De hecho, la inhibición de la 
competición celular produce una acumulación de células en proceso de 
diferenciación. Estas observaciones correlacionan con resultados obtenidos en 
estudios realizados en epiblasto de ratón. Además, demostramos que la eficiencia 
competitiva viene directamente determinada por los niveles de Myc 
independientemente del estado de pluripotencia. 
 
Estos resultados señalan a Myc como un intermediario entre el estado de 
diferenciación y la capacidad competitiva de las células pluripotentes. Por lo tanto, la 
competición celular endógena promovida por Myc funciona como un mecanismo de 
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Video 1. ESC colony showing GFP-Myc levels (green) and tdTomato reporting the 
cell membrane (red). 
 
Video 2. ESC colony showing cell segmentation and tracking. Colors when 
segmented represent different cell identities. 
 
Video 3. ESC colony displaying segmented nuclei, with green levels representing 
endogenous GFP-Myc levels. ID labeling across mitosis shows cell tracing. 
 
Video 4. Caspase3 activity (red) reporter identifying an apoptotic cell (arrow) in an 
ESC colony. 
 
Video 5. Hoechst58 (blue) identifying an apoptotic cell (arrowhead) in an ESC 
colony. 
 
Video 6. ESC colony showing a dying cell. These cells are easily recognized by the 
changes in the membrane, which collapses during apoptosis. 
 
Video 7. ESC colony tracing the movements of a PCD (loser) and its associated PCD-
MHN (winner) in the time period preceding loser death. 
 
Video 8.  An iMOST1-myc ES colony showing the onset of EYFP-Myc-overexpression 
cells following tamoxifen induction. 
 
Video 9. An iMOST1-myc ES colony showing the death of cells (arrowheads) 
neighboring EYFP-Myc-overexpressing cells. 
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Cell competition consists in the fitness comparison between viable 
neighbouring cells resulting in the elimination of the less fit cells (Figure 1). This 
phenomenon was firstly described in Drosophila and currently has been 
characterized in many biological scenarios and is envisioned as an important tissue 
homeostatic mechanism in metazoans.  
 
In mammals, pluripotent cells of the early mammalian embryo show a natural 
cell-to-cell heterogeneity in Myc levels, which leads to the competitive elimination of 
Myc-low cells from the embryonic lineage. The mechanism and the biological 
relevance of this phenomenon, however remain unknown. In this thesis, we aim to 
elucidate the mechanisms and biological basis of endogenous cell competition 
regulated by Myc in the context of Embryonic Stem Cells (ESCs) and the early 
mammalian embryo. 
 
1. Cell competition 
 
1.1. The discovery of Cell Competition: early studies in flies	  
	  
	  
Forty years ago, Ginés Morata and Pedro Ripoll reported the phenomenon 
while studying the proliferation of Drosophila cells mutant for Minute genes, in 
which ribosomal proteins are affected. Minute mutations affect protein synthesis 
ability and produce cellular lethality in homozygosis, while heterozygous flies are 
viable and nearly normal but show slower development due to a reduced proliferative 
rate. When a mosaic of heterozygous (M/+) and wild-type (WT) cells were induced in 
wing imaginal discs, M/+ cells, which otherwise would be viable, were eliminated due 
to confrontation with WT cells (Morata and Ripoll, 1975) (Figure 1). Simpson 
confirmed the previous observations and observed that elimination of M/+ clones in 
a WT background did not take place when larvae were starved.  Since starvation 
induces generally reduced growth rates, these experiments strongly suggested that a 
limitation of growth/proliferation of M/+ determines the competitive elimination of 
M/+ cells and that the mechanism underlying M/+ cell depletion was related to the 
metabolic control of cell growth (Simpson, 1979). The requirement of a differential 




of Minute mutations with variable severity (Simpson and Morata, 1981). In these 
models, competition did not affect the final size of the wings or compartments, 
suggesting the compensatory proliferation of WT cells. Moreover, cell competition 
was shown by these studies to result from local interactions between slow- and faster-
growing cells (Simpson and Morata, 1981). However, cell competition was ineffective 
across compartment borders and WT clone expansion was restricted to well-defined 
and reproducible frontiers, which suggests that wing disc are divided in non miscible 
cell populations (compartment boundary) (Simpson and Morata, 1981).  
 
It was not until many years later that cell competition became again a subject 
of interest when the phenomenon was reported to require short-range interactions 
and to be executed by apoptosis of loser cells in Drosophila imaginal discs (Abrams, 
2002; Milan et al., 2002; Moreno et al., 2002). 
 
 
Figure 1.  Cell competition and supercompetition. 
 
Schematic representation of the cell competition process. In cell competition, 
information about fitness status is locally exchanged between cells. Less fit, but 
otherwise viable, cells are outcompeted by higher-fitness cells undergoing apoptosis. 
Loser cells are replaced by fitter winner cells, which overproliferate.  
High-fitness cells generated in a WT background also lead to the elimination of the WT 





1.2. Supercompetition and the transcription factor Myc 
 
Supercompetition is as a type of cell competition in which cells with 
experimentally increased fitness eliminate neighbouring WT cells, thereby 
overcolonising tissues (Abrams, 2002) (Figure 1). The first gene to be linked to this 
definition was the proto-oncogene dMyc. dMyc is the fly homologue of the 
mammalian family of Myc transcription factors and regulates many downstream 
targets involved in cell growth and cell anabolism (Johnston et al., 1999; de la Cova 
and Johnston, 2006). In 2004 two pioneer papers presented the role of this proto-
oncogene in cell competition by inducing dMyc overexpressing clones in the wing disc 
(de la Cova et al., 2004; Moreno and Basler, 2004). These clones were able to expand 
at the expense of WT cells until they filled the compartment (Figure 1). Apoptosis via 
JNK (Moreno and Basler, 2004) and hid activation in the loser cells (de la Cova et al., 
2004) was required in this process. In this context, dMyc-overexpressing cells acted 
as “supercompetitors” and the WT cells behaved as “losers” (Figure 1). The discovery 
of supercompetition induced by Myc led to propose that early steps of tumour 
formation could be driven by this phenomenon (Rhiner and Moreno, 2009), which 
generated a new wave of interest in cell competition. 
 
On the contrary, downregulation of dMyc in cells led to their elimination, in 
similarity to observations with M/+ clones (Johnston et al., 1999; de la Cova et al., 
2004; Moreno and Basler, 2004). This suggested that dMyc was a general driver of 
cell competition by controlling cell’s anabolic machinery. Interestingly, cells with two 
extra dMyc copies, which behave as supercompetitors in front of WT cells, instead 
behaved as “losers” when confronted with cells with four extra copies of dMyc 
(Moreno and Basler, 2004) supporting the idea that competition is based on 
intercellular comparison of relative Myc levels and not on cell-autonomous sensing of 
absolute Myc level.  
 
In addition, these studies ruled out a strict relationship between cell growth or 
proliferative activity and competitive ability, since overexpression of factors inducing 
cell growth (PI3K Dp110) or cell cycle regulators (CyclinD and Cdk4) generated large 




and no other proliferation/growth regulators affect specific competitive pathways (de 
la Cova et al., 2004; Moreno and Basler, 2004).  
 
1.3. Pathways involved in cell competition in Drosophila 
 
After the discovery of Minute and Myc-driven competition, many studies have 
tried to shed light on this field by finding out new pathways and molecules involved 
in this process. These factors can be classified into two groups depending of the kind 





The first group includes factors that affect metabolic pathways and are likely to 
induce cell competition by producing contrasting anabolic ability in neighbouring 
cells (Figure 2).  This group includes the classical factors inducing cell competition, 
like Minute mutations, the BMP/Dpp pathway and Myc. This group also includes 
other pathways involved in growth/survival signal reception or transduction to the 
cell’s anabolic machinery, such as the Rab5 and Vps25 endocytic pathways (Moreno 
and Basler, 2004; Herz et al., 2006), the Ras/MAPK pathway (Prober and Edgar, 
2000) and the JAK/STAT pathway (Rodrigues et al., 2012). In addition, cell 
competition can also be induced by mutations in the Salvador/Warts/Hippo pathway, 
which is a central regulator of growth, cell death and tissue homeostasis (Tyler et al., 
2007; Neto-Silva et al., 2010; Ziosi et al., 2010; Chen et al., 2012).  The nature of 
competitiveness regulation by these pathways is likely similar, since hierarchical 
regulatory interactions have been established between the various pathways involved 
in metabolic cell competition. Myc acts downstream of various cell competition-
inducing pathways like the BMP/Dpp (Doumpas et al., 2013), Ras/MAPK  (Prober 
 
Figure 2. Pathways involved in metabolic and structural competitive 
fitness. 
 
Schematic of the main pathways involved in structural and metabolic cell competition. 
Cell selection is initiated by mutations or pathways that generate differential fitness 
activity between neighbouring cells triggering cell competition. On one hand, metabolic 
fitness is determined by the anabolic activity of the cell, specifically by protein synthesis 
machinery. This machinery is activated by Myc, on which cellular growth and 
proliferative pathways converge. Even though the JAK/STAT pathway does not depend 
on Myc signalling, it also affects cell metabolic fitness. 
On the other hand, structural fitness is determined by the apico-basal polarity 
machinery. When polarity pathways are mutated the structural fitness is decreased and 
the SWH pathway is repressed leading to an increase in growth/proliferation. Since 
competitive behaviours between isolated mutant and surrounding WT cells counteract 
SWH pathway repression by JNK, polarity-deficient cells are thus outcompeted. 
However, when polarity-deficient cells elude competition, SWH pathway is effective and 
trigger overgrowth of mutant cells. The Notch pathway and the endocytic pathway 
(Rab5, Vsp25) may interact with both metabolic and structural fitness pathways, but 
their specific involvement has not been reported yet.  
Ellipses in red represent factors whose gain of function increases fitness and blue 
ellipses represent those factors whose gain of function reduce fitness.  
Filled arrows indicate activation, whereas bars mean inhibition or blockade of target 
activity. Dashed lines show a deduced effect and a solid line indicates a known 





and Edgar, 2000; Moreno and Basler, 2004) and SWH (Neto-Silva et al., 2010; Ziosi 
et al., 2010). Moreover, BMP/Dpp signal transduction is enhanced by a positive 
feedback that involves Myc and enhanced protein synthesis is required downstream 
of Myc to induce cell competition (Moreno and Basler, 2004). Although the STAT 
pathway does not show any apparent epistatic relationship during cell competition 
with the Myc, SWH, or Minute pathways (Rodrigues et al., 2012), it seems to affect 
the same cellular parameters, because Myc-low cells are rescued by STAT 
hyperactivation and STAT-deficient cells are rescued when confronted with Minute 
mutant cells (Rodrigues et al., 2012). 
 
The second group of cell competition inducers includes factors affecting 
polarity and epithelial integrity and therefore define a different class of competitive 
interactions known as structural cell competition (Figure 2). Extrusion from the 
epithelium is the typical way of eliminating cells in this type of competition and cell 
death is not always involved in this process. Structural cell competition is induced by 
alterations affecting components of the canonical pathway regulating apico-basal 
polarity, such as Lgl (Menendez et al., 2010; Tamori et al., 2010), Scribble (Brumby 
and Richardson, 2003), Dlg (Woods and Bryant, 1991), Mahjong/VprBP (Tamori et 
al., 2010) and Crumbs (Hafezi et al., 2012). In addition, the role of Rab5 and Vps25 
in cell competition may also be related to the structural organization of the cell, since 
the endocytic pathway also affects apico-basal polarity (Lu and Bilder, 2005). Yet, 
although there is also cross talk between structural and metabolic cell competition, 
these pathways have very different natures. In fact, in various cases, the mutations 
that induce the loser phenotype in structural competition, however promote 
metabolic changes typical of winner cells in metabolic competition, indicating that 
structural alterations in epithelial tissues overrule metabolic activity in competitive 
interactions.  An additional difference is that both winner and loser cells in metabolic 
competition usually respect normal tissue architecture, while winners or losers in 
structural cell competition can produce tumorous growth. 
 
Finally, there are some other pathways that induce cell competition but whose 
mechanisms and relationships to the canonical pathways have not been completely 
resolved, such as the Wnt pathway (Vincent et al., 2011; Rodrigues et al., 2012) or 




1.4. Cell competition in mammals 
 
The first study suggesting that cell competition could also take place in other 
metazoans than insects was the analysis of a mouse mutation equivalent to the fly 
Minute mutants. The Bst mice mutants are defective in ribosomal protein L24. While 
Bst homozygous mutant mice are not viable, heterozygous mice showed a kinked tail, 
decreased pigmentation and retinal defect but are viable and normal-sized (Oliver et 
al., 2004). As in the Drosophila system, cells heterozygous for RpL24 were 
disproportionately disadvantaged with respect to WT cells in mouse chimeras (Oliver 
et al., 2004). However, whether this observation was due to cell autonomous features 
of the Bst mutants or indeed reflects competitive interactions has not been addressed.  
 
A second study pointed out to the occurrence of cell competition in liver 
regeneration. In aged rat livers, host hepatocytes were outcompeted by transplanted 
fetal hepatocytes, apparently by local interactions that promoted resident hepatocyte 
death, which facilitated long-term repopulation post-transplantation (Oertel et al., 
2006). 
 
Following these pioneering studies, cell competition based on stress and 
mediated by p53 was described (Figure 2).  Stress signals induce p53-mediated cell 
death in Drosophila and either cell death or cell cycle arrest and repair in mammals.  
In bone marrow transplants, cells sublethally irradiated behaved as losers in a p53-
dependent manner when confronted with non-irradiated cells (Bondar and 
Medzhitov, 2010). In addition, when a mosaic p53 mutant bone marrow is irradiated 
only p53-deficient clones were recovered (Marusyk et al., 2010). In these two studies, 
a senescence-like phenotype, rather than apoptotic elimination, was induced in the 
outcompeted cells (Bondar and Medzhitov, 2010; Marusyk et al., 2010). In this 
context, cell competition would be the result of cells comparing their p53 activity 
levels, resulting in the outcompetition of the p53-high population. Given the role of 
p53 in transducing stress situations, this mechanism would ensure the elimination of 
stressed cells whenever unstressed cells are available in the surroundings. 
 
Epithelial monolayers in culture derived from the Madin-Darby canine kidney 




competition in mammalian cells. Studies with structural cell competition pathways 
have shown that mutations in Lgl, its partner Mahjong (Tamori et al., 2010) or 
Scribble (Norman et al., 2012) induce cell competition in the MDCK culture system. 
 
Figure 3. Schematic representation of the iMOS system construction. 
 
A. A recombinase-based system for genetic mosaic induction was obtained by using two 
different loxP sequence variants that recombine with homotypic but not heterotypic 
sequences. The three cassettes flanked by the loxP sites end in a triple polyadenylation 
signal blocking the expression of the following transcriptional units. Upon Cre 
expression, either the transcriptional unit T0 is excised, leading to the expression of T1 
or both T0 and T1 are eliminated leading to the expression T2. This system allows to 
randomly generate a mosaic with two labelled cell populations. The construct is targeted 
to the ubiquitous Rosa26 locus, whose expression gives rise to a policistronic mRNA 
expressing a buffer sequence or a protein of interest and a fluorescent reporter protein, 
either the yellow fluorescence protein (EYFP) or the cyan fluorescent protein (ECFP). 
The recombination frequency of EYFP cells is 75% and that of the ECFP cells 25%. This 
difference is due to the different distances between the loxP sites. B. Schematic 
representation of the iMOS lines used in this thesis. In iMOSWT, both labelled population 
are WT. iMOST1-Myc generates an EYFP Myc-overexpressing cell population and an ECFP 
WT population. In iMOST2-p35, EYFP cells are WT while ECFP cells express the 






This model also showed the so-called Epithelial Defence Against Cancer 
(EDAC) which consists in the competitive elimination of cell carrying oncogenic 
mutations, like Rasv12 or Src, by apical extrusion from the epithelial sheet (Hogan et 
al., 2009; Kajita et al., 2010). In this model maintenance of epithelial homeostasis 
only occurs when WT cells win, whereas when the defective cells escape from cell 
competition, they give rise to tumour formation (Hogan et al., 2009; Kajita et al., 
2010).  
 
Additional cases of cell competition have been recently described when cells 
lacking the Notch pathway are confronted with WT cells in the adult mouse 
esophageal epithelium (Alcolea et al., 2014) (Figure 2). WT cells were progressively 
eliminated from the tissue by their Notch-deficient neighbour clones, which 
underwent overgrowth (Alcolea et al., 2014). 
 
Furthermore, recent studies have shown that Myc-dependent cell competition 
also takes place in the early mouse embryo. Myc-induced supercompetition was 
characterised in mouse embryos by using a system of inducible mosaics based on Cre 
recombination, which generated two different populations (Claveria et al., 2013) 
(Figure 3). One cell population overexpressed Myc under the expression of the 
ubiquitous Rosa26 promoter and the other population remained WT and was 
selectively eliminated from the epiblast (Claveria et al., 2013). This demonstrated 
that supercompetition could also be induced in the embryo and that it provoked the 
phenotypically silent replacement of WT cells. In addition, it was shown that 
apoptosis of WT loser cells was needed for this replacement and that competition was 
contact-dependent, was apoptotic rate was increased in WT cells in direct contact 
with Myc overexpressing cells (Claveria et al., 2013). In this study cell competition 
was also explored in vitro in mouse ESCs, where Myc induced cell competition could 
also be shown (Claveria et al., 2013). In a similar study, it was reported that Bmpr1a 
(BMP receptor 1a) knock out ESCs decreased their Myc levels when compared with 
their WT counterparts and were subsequently outcompeted (Sancho et al., 2013). 
Interestingly, it was also reported that Myc activation led to induced cell competition 
in several tissues and organs of the developing and adult mouse (Claveria et al., 2013; 





All these assays performed in mammalian models demonstrated that cell 
competition is widespread in metazoans and not restricted to just Drosophila wing 
discs or Minute mutations.  In addition, they identify the Myc pathway as a conserved 
central regulator of cell competition. 
 
1.5. Endogenous cell competition 
 
All of the mentioned findings so far rely on experimental introduction of stress 
or mutations and did not address the potential roles of spontaneous cell competition 
in normal development or tissue homeostasis.  Endogenous cell competition however 
has been detected in the mouse epiblast, where cells express naturally heterogeneous 
levels of Myc (Claveria et al., 2013; Sancho et al., 2013) (Figure 4). During the 
different phases of epiblast development, abundant cell death is observed, showing a 
peak at 6 days of development, just before the onset of differentiation and 
gastrulation (Poelmann, 1980; Heyer et al., 2000; Plusa et al., 2008). This maximal 
incidence of death is partially due to sensitivity to DNA damage and mediated by a 
p53-dependent quality check (Heyer et al., 2000) and in part regulated by Myc levels 
(Claveria et al., 2013). Epiblast cells with lower Myc levels preferentially undergo 
apoptosis due to their confrontation with neighbours with higher Myc levels.  This 
elimination thus results in the recruitment of the pool of cells with higher Myc levels 
to the developing embryo (Figure 4). When cell death is inhibited by p35 
overexpression, rescued cells express relatively lower Myc levels than the rest, 
indicating that in normal conditions the Myc-low cell population is eliminated 
(Claveria et al., 2013). Spontaneous cell competition between cells expressing 
contrasting Myc levels was also detected in mESC cultures (Claveria et al., 2013). 
However, the biological basis, dynamics and mechanisms of Myc-mediated cell 
competition remain unknown. 
  
An additional example of endogenous competition has recently been reported 
for T-cell progenitors in the mouse thymus (Martins et al., 2014). Bone marrow 
derived colonizing cells outcompeted resident progenitor cells upon competition for 
the survival factor Interleukin7. Cell competition was needed to continuously 




(Martins et al., 2014). Since abolishment of this replacement led to cancerous 
formation of thymic cells, cell competition would be playing a tumour suppressor role 
in this phenomenon.  
 
Finally, cell competition has been shown to counter-select naturally viable, but 
suboptimal cell clones in mammalian fibroblasts (Penzo-Mendez et al., 2015). 
 
1.6. Mechanisms of cell competition 
 
The mechanisms by which cells are able to compare their fitness have been 
intensively investigated.  Although several hypotheses have been proposed trying to 
clarify how competitive interactions occur, complete understanding of the 
 
Figure 4. Endogenous cell competition. 
 
During normal mouse development, Myc levels in the epiblast are intrinsically expressed 
in a heterogeneous pattern. This produces contacts between cells with high and low-Myc 
levels, which are fitter and less fit cells, respectively. Myc discrepancies between 
neighbouring cells leads to outcompetition of the less fit population and a selection of the 
epiblast cell pool. This process refines the epiblast cell population, giving rise to a final 






phenomena observed is far from complete. The different mechanisms and 
interactions proposed to take place between competing cells are explained here. 
 
1.6.1. Ligand capture model 
 
This was the first model discussed (Morata and Ripoll, 1975), and received 
support from studies indicating that cells compete for growth/survival factor signals 
(Moreno et al., 2002). This model was supported by the observation that loser cells 
presented lower level of Dpp signalling (a secreted protein member of the TGFb 
family and the fly orthologue of mammalian BMPs) and an excess of Brinker 
activated by the JNK pathway and triggering apoptosis (Moreno et al., 2002). 
However, in several studies the Dpp distribution does not correlate with the intensity 
of cell competition (Burke and Basler, 1996; de la Cova et al., 2004; Martin et al., 
2009). Moreover, in various scenarios where Dpp growth factors are present in 
excess still competitive behaviours take place (Senoo-Matsuda and Johnston, 2007; 
Hogan et al., 2009; Tamori et al., 2010; Norman et al., 2012; Claveria et al., 2013; 
Sancho et al., 2013; Mamada et al., 2015). All these observations suggest that Dpp 
signalling might result from the execution of competitive program more than being 
its driving force. 
 
Even though this model gave gratifying explanations, the trophic theory did 
not address many aspects related to the phenomena, such as the related 
compensatory proliferation or the mechanism of fitness comparison (Adachi-Yamada 
and O'Connor, 2002; Gibson and Perrimon, 2005; Shen and Dahmann, 2005). 
 
1.6.2. Models based on fitness reporting 
 
This type of models propose that cells directly report their fitness status to 
neighbouring cells resulting in the dismissal of cells with comparative lower fitness. 
The Flower pathway has been the first model proposed for this kind of interaction 
(Rhiner et al., 2010). Flower is a transmembrane protein ubiquitously expressed in 
Drosophila. This protein has three isoforms differing in their C-terminal regions that 
are exposed to the extracellular space. Less fit cells specifically express one of the 




when surrounding cells express the ubiquitous form (Rhiner et al., 2010). The Flower 
code has been observed to function in a variety of scenarios, such as cell competition 
driven by Minute, Myc, Dpp and Scribble, however it is not detected when apoptosis 
is induced by direct cell death inducers (Rhiner et al., 2010). Since loss of Flower 
neither affects growth nor homeostasis of tissues, Flower has been proposed to 
function as a label of loser cells, being considered a dedicated effector of cell 
competition. 
 
Finally, Crumbs has also been shown to report fitness between prospective 
winner and loser cells (Hafezi et al., 2012) (Figure 2). As mentioned previously, 
Crumbs is a transmembrane protein component of the apico-basal polarity system. 
This protein differentially expressed in neighbouring cells determining the winner 
and loser fate in a context-dependent manner and mutations that alter fitness also 
alter Crumbs levels (Hafezi et al., 2012). 
 
However, the molecular mechanisms involved in the ability of the Flower and 
Crumbs systems to mediate quantitative fitness comparison between cells is still 
unresolved. 
 
On the other hand, other authors have proposed the release of diffusible 
signals as a mechanism to report fitness. This concept emerged from experiments 
where Drosophila S2 WT cells were out-competed when co-cultured with Myc-
overexpresing cells separated by a permeable membrane (Senoo-Matsuda and 
Johnston, 2007). Additional experiments showed that conditioned medium from 
cultures undergoing Myc-induced competition, but not from cultures expressing Myc 
in a homogenous manner, was able to induce WT cell death (Senoo-Matsuda and 
Johnston, 2007). These studies suggested a model in which diffusible factors 
produced during competition induce loser cell elimination. In this model, prospective 
loser cells are not specifically targeted, and therefore winner cells should activate a 
mechanism that protects them or sensitizes loser cells to the killer signal. The 
combination of the killing signal with winner-specific resistance to it would constitute 
the fitness comparison mechanism. These experiments however may only apply to 
certain models of cell competition, since similar experiments in Drosophila (Portela 




mouse fibroblasts, conditioned medium experiments did not induce cell competition 
and apoptosis was only increased in cells adjacent to Myc-overexpressing cells 
(Claveria et al., 2013; Penzo-Mendez et al., 2015). In contrast, in BMP-induced mESC 
cell competition models, diffusible signals were reported to be responsible for 
competitive interactions (Sancho et al., 2013). Remarkably, in vivo studies show that 
very short range or direct contact was needed for the elimination of less fit cells 
(Simpson and Morata, 1981; Moreno et al., 2002; Moreno and Basler, 2004; Li and 
Baker, 2007; Claveria et al., 2013) and that cell competition does not cross 
compartment boundaries (Simpson and Morata, 1981), therefore even in the 
scenarios in which diffusible factors are involved, they would mostly act locally. These 
results suggest that the molecular mechanism that determine competitive 
interactions may depend on the model being studied and further analysis needs to be 
done to elucidate this question and identify the putative signals involved. 
 
Possible examples of competition based on diffusible molecules have been 
recently reported.  An innate immunity-related recognition mechanism has been 
characterised in cell competition in Drosophila imaginal discs (Meyer et al., 2014). In 
this study, it was shown that activation mediated by the diffusible signal Späztle of 
Toll-related receptor is required for low-Myc and elimination of Minute mutant cells 
(Meyer et al., 2014). Another diffusible killer activity has also been identified during 
neuronal competition for target innervation in mammals (Deppmann et al., 2008).  
 
1.6.3. Mechanical models 
 
Several studies have proposed mechanical stress as an independent inducer of 
cell competition in epithelia, where cells compete for limited available space 
(Shraiman, 2005; Eisenhoffer et al., 2012; Marinari et al., 2012; Paoli et al., 2013). 
These models may be applied to structural cell competition, where alterations in the 
apico-basal polarity can alter attachment forces among cells and between cells ant the 
basal membrane. Mechanical stress seems not to be involved in metabolic cell 
competition (Senoo-Matsuda and Johnston, 2007; Claveria et al., 2013; Sancho et al., 
2013; Mamada et al., 2015; Penzo-Mendez et al., 2015). In addition, entosis has been 
shown to be the predominant mechanism of cell competition between Ras-Rac-




death initiated when living cells are engulfed by other cells of the same kind 
(Overholtzer et al., 2007). The ability of a cell to engulf can determine the winner and 
loser phenotype in some models and is determined by mechanical differences 
between cells.  High deformability controlled by RhoA and actomyosin was reported 
to be sufficient to explain the winner status, whereby this higher deformability 
enables cell to engulf their neighbours (Sun et al., 2014b). In addition, E-cadherin 
overexpression transformed cells induce entosis-mediated cell competition (Sun et 
al., 2014a). Nevertheless, in some cases the inner cell escapes and does not die, 
suggesting that cell engulfment events do not always lead to cell death and that the 
strive for survival of the engulfed cell might represent a fitness status test 
(Overholtzer et al., 2007).  
 
1.7. Loser cell clearance and replacement 
 
Several mechanisms have been proposed for the clearance of cell corpses after 
the activation of the apoptotic pathway in those cells. Extrusion from the epithelial 
layer and phagocytosis are the two main mechanisms for eliminating loser cells.  In 
vertebrate models apical extrusion is predominant (Gu and Rosenblatt, 2012; Lolo et 
al., 2013) while basal extrusion is predominant in Drosophila epithelia (Grzeschik et 
al., 2010; Tamori et al., 2010; Lolo et al., 2013), where dead cells are engulfed and 
remove by haemocytes (Lolo et al., 2012). The sphingosine-1-phosphate and Rho 
pathways have been shown to be involved in extrusion of dead cells (Gu et al., 2011) 
and release of tyrosyl-tRNA synthetase by loser cells stimulates hemocyte 
recruitment and phagocytic activity (Casas-Tinto et al., 2015). 
 
 In the Minute model, some studies report that engulfment seems to be the 
main system to eliminate Minute mutant cells (Li and Baker, 2007). In this context, 
mutations in essential components for the phagocytic process prevent competition 
suggesting that engulfment may be upstream of the initiation of the death machinery 
(Li and Baker, 2007), however these findings have not been confirmed in further 
experiments (Lolo et al., 2012).  Studies have also reported the elimination of polarity 
mutant cells by engulfment (Ohsawa et al., 2011), contrasting with others in which 
this process seems not to be required for elimination of the Minute mutant cells, 




al., 2012). Engulfing by neighbouring cells is also observed in mouse ES and epiblast 
cells (Claveria et al., 2013). Notably, in these scenarios complete engulfment of intact 
cells is observed, suggesting that entosis may be involved in the competition process, 
although further studies would be needed to confirm this (Claveria and Torres, 2016). 
 
After dead cell elimination, expansion of the winner cells allows the 
replacement of the loser population. Proliferation signals produced by loser cells 
stimulate this compensatory growth, and these signals may be stress-induced or 
apoptosis-induced (Claveria and Torres, 2016). Interestingly, a proliferative state is 
not required for cell competition.  In a model of postmitotic competition in the 
Drosophila ovarian epithelium, winner cells undergo hypertrophy instead of 
overproliferation to fill the space left by the loser population (Tamori and Deng, 
2013). 
 
1.8. Physiological roles of cell competition 
 
Cell competition is a mechanism senses and optimizes cell fitness in a wide 
variety of contexts. An important remark is that while cellular fitness is an intrinsic 
property cells, the outcome of cell competition is determined by fitness comparison 
with neighbours. The role of cell competition as a fitness-quality control suggests that 
this mechanism is important in maintaining healthy tissues and its failure might be 
involved in a wide range of diseases. However, most cell competition models reported 
are experimentally induced, which limits the identification of its physiological roles. 
Investigations of natural cell competition need to be explored further, however this is 
hampered by the pleiotropy of the majority of the pathways involved in this 
phenomenon (Claveria and Torres, 2016). 
 
1.8.1. Tissue quality control 
 
The first study describing cell competition, already suggested that it could 
function as a potential quality control mechanism through eliminating less fit cells 
(Morata and Ripoll, 1975). Later experiments also suggested a role in regulating 





Myc-driven endogenous cell competition in the pregastrulation embryo 
(Claveria et al., 2013) suggests the implication of competitive behaviours in a natural 
quality control checking in the epiblast.  Interestingly, due to the pluripotency of 
epiblast cells, these can be eliminated and replaced without compromising embryo 
development (Claveria and Torres, 2016).  
 
Recently, Azot has been characterized as a mediator of apoptosis induction 
specifically in several types of cell competition, but not in other stress-response 
pathways, in Drosophila (Merino et al., 2015). The function of Azot in cell death 
induction is therefore strongly linked to cell competition-induced cell death. Loss of 
Azot leads to accumulation of defective cells and premature aging (Merino et al., 
2015), indicating an important role of tissue quality control during Drosophila 
development and adult tissue homeostasis.  
 
An interesting example of natural cell competition controlling tissue quality is 
the analysis of lineage displacement in the Drosophila female germline, in which cell 
competition has been proposed to maintain the boundaries between the GSC niche 
and the differentiating compartment (Jin et al., 2008; Rhiner et al., 2009). 
Therefore, the proposed function of cell competition is GSC stemness maintenance, 
although its relevance in maintaining GSC quality during normal oogenesis has not 




Several studies suggest the implication of cell competition in regeneration. 
When fetal hepatocytes are transplanted into a damaged adult liver, transplanted 
cells replace resident cells by progressively eliminating them (Oertel et al., 2006). 
This colonization of the tissue is not only due to their increased proliferative activity, 
but also to the induction of cell death of the adult hepatocytes localized close to 
transplanted cells (Oertel et al., 2006). In addition, experiments in mouse adult heart 
show that Myc-overexpressing cardiomyocytes can replace WT cells without 
modifying the function and anatomy of the heart, suggesting a potential role of cell 




2014).  More recently, in a model of Drosophila neural regeneration, it has been 
shown that the comparison of neuronal fitness leads to the elimination of non-




Finally, the relevance of cell competition for cancer has been extensively 
hypothesized and explored. Interestingly, cell competition has been characterized 
both as a tumour-suppressing and as tumour-promoting mechanism.  
 
On one hand, although the expression levels that drive metabolic cell 
competition do not disrupt normal development or tissue homeostasis, the pathways 
involved in promoting the winner phenotype promote oncogenesis in humans and 
tumour formation in experimental models (Claveria and Torres, 2016). 
Supercompetition has been linked to field cancerization models in which cells 
carrying pre-oncogenic lesions silently expand in tissues at the expense of 
surrounding normal cells (Rhiner and Moreno, 2009). Examples of this are the 
expansion of Kras mutation in the intestine (Snippert et al., 2014) and Notch 
mutations in the oesophagus (Alcolea et al., 2014), both driving experimental field 
cancerization. Other studies connect flower deficiency (Petrova et al., 2012) and 
SPARC overexpression (Petrova et al., 2011; Yamada et al., 2015) with tumour 
formation. More recently, cell competition has also been implicated in tumour 
expansion and invasiveness once the tumour is established (Eichenlaub et al., 2016; 
Suijkerbuijk et al., 2016). 
 
On the other hand, the pathways involved in structural cell competition are 
also linked with oncogenesis and carcinoma formation in a variety of tissues. In this 
case, the tumour-promoting phenotype is mostly associated with the loser fate, 
indicating a tumour supressing role for cell competition (Kajita and Fujita, 2015; 
Claveria and Torres, 2016). Other experiments show a tumour-suppressing role when 
mutations affect individual cells or small number of cells but a tumour-promoting 





2. Early development of the mouse embryo, ESCs and pluripotency 
 
2.1. From fertilization to gastrulation 
 
Development of the zygote or fertilized egg proceeds through symmetric 
cleavage divisions until the morula is formed. Cells at the early morula stage are 
totipotent blastomeres, which are able to give rise to all embryonic and extra-
embryonic lineages (Gardner, 1998). Removal of one or more cells at this stage (6 to 
8-cell embryo) does not affect normal development (Nichols and Smith, 2009). 
Moreover, the fate of the individual cells can be manipulated by changing their 
position within the embryo (Hillman et al., 1972) (Figure 5).  
 
After a fixed number of cell cycles, the individual blastomeres compact and at 
32-cell stage those blastomeres on the periphery differentiate and form an epithelium 
called trophectoderm (TE) (Selwood and Johnson, 2006) while a group of cells 
known as the inner cell mass (ICM) remain internal and pluripotent.  Pluripotency is 
defined as the ability to generate all embryonic cell lineages but not the complete set 
of extraembryonic tissues. The appearance of the blastocoel, a cavity below the TE 
produced by fluid pumping, generates the blastocyst (Nichols and Smith, 2009).  The 
ICM then segregates in epiblast, constituted by pluripotent cells precursors of the 
embryo proper, and the hypoblast or primitive endoderm (PE), which mostly 
contributes to extraembryonic or non-definitive endoderm. At E3.5, before 
implantation in the uterus, the three lineages of the blastocyst are well established 
and this process is autonomous with respect to external cues from fertilization to 
implantation (Figure 5).  
 
Initial models of epiblast-primitive endoderm segregation considered the early 
ICM as a homogeneous population in which cells were allocated to the two lineages 
according to their position with respect to the blastocoel (Chazaud et al., 2006). 
However, later studies showed that the ICM is already heterogeneous at E3.5.  The 
random “salt and pepper” expression of two transcription factors in a mutually 
exclusive manner, Nanog and Gata6, determines the two lineages within a single cell 




endoderm, facing the blastocoel, and the epiblast, positioned between the 
trophectoderm and the primitive endoderm (Chazaud et al., 2006) (Figure 5). 
 
 
Figure 5. Overview of some stages of early mouse embryogenesis. 
 
Frontal view of the pre- and post-implantation embryo at different stages. The zygote 
undergoes symmetric cleavages giving rise to the morula, which is then compacted. At E3 
blastomeres start to segregate and form the trophectoderm, which is the first event of 
differentiation. At E3.5, the second event of differentiation takes places and some cells 
from the inner cell mass form the primitive endoderm. Later, the blastocyst hatches from 
the zona pellucida and implants in the uterine wall. The primitive endoderm migrates to 
become the parietal and visceral endoderm, which covers the epiblast. At E6, the epiblast 
is a monostratified epithelium. Gastrulation begins at E6.5 when some cells of the 
posterior pole undergo an epithelial-mesenchymal transformation to generate mesoderm 





Later, the blastocyst hatches from the zona pellucida and implants in the 
uterine wall. As a natural selection checkpoint, only embryos able to hatch continue 
developing, invading the maternal tissue and implanting (Bedzhov et al., 2014). After 
implantation, the trophectoderm becomes the trophoblast and contributes to 
extraembryonic membranes, while the epiblast generates the embryo plus some 
extra-embryonic tissues. In the first two days post-implantation, the mural 
trophectoderm (cells that surrounds the blastocyst cavity that are not in contact with 
the ICM) gives rise to polyploid Trophoblast Giant Cells (TGCs), which represent the 
first terminally differentiated cell type (Bedzhov et al., 2014). Contrary to this, the 
polar TE, which surrounds the outer surface of the ICM, is the source of multipotent 
progenitors, the TE stem (TS) cells. These cells proliferate and become the 
ectoplacental cone (EPC) that builds the proximal half of the egg cylinder and later 
contributes to the placenta, and the extraembryonic ectoderm (ExE). The primitive 
endoderm migrates to become the parietal endoderm, which covers the inner surface 
of mural TE, and the visceral endoderm, which covers the egg cylinder and epiblast. 
By six days after fertilization, the epiblast is a cup-shaped monostratified epithelium 
of ~1000 cells (Figure 5). 
 
At 6.5 days after fertilization the first morphological sign of embryonic 
patterning is evident when gastrulation begins (Beddington and Robertson, 1999). 
Some cells of the future posterior pole of the epiblast, which is apparently a 
homogeneous epithelium, undergo epithelial-mesenchymal transformation (EMT) to 
generate mesoderm and form the primitive streak (Beddington and Robertson, 1999). 
Cells move through the streak and spread forward to form mesoderm. The visceral 
endoderm is replaced by the definitive endoderm that derives from the epiblast 
(Figure 5). During the next hours, the streak elongates from the rim to the distal tip of 
the cup and the node forms. This specialized structure is considered homologous to 
the organizer of other vertebrate embryos and gives rise to the axial gastrulating cells 
that comprise the axial mesoderm (future prechordal plate and notochord) and the 






2.2. Embryonic Pluripotency: defining the Naive and Primed 
pluripotent states in mammalian development 
 
The mammalian egg is totipotent as it can give rise to the entire embryo. 
However, this does not mean that the zygote can directly differentiate into the all cell 
types. In fact, the egg and the blastomeres derived from it produce directly only two 
types of cells: trophectoderm cells and cells from the inner cell mass (Nichols and 
Smith, 2009). 
 
As mentioned before, pluripotency is the capacity of cells to produce all three 
embryonic germ layers, but not trophectoderm-derived extra-embryonic tissues 
(Hanna et al., 2010). Pluripotency is not a single status, but evolves in a highly 
dynamic manner through different stages of pre- and post-implantation 
development. To develop, the ICM must be able to generate other cell types in a 
flexible manner (Gardner and Beddington, 1988; Nichols and Smith, 2009). The 
early ICM is the founder pluripotent population.  Once it segregates into PE and 
epiblast at the late blastocyst stage, the epiblast retains the pluripotency, while the PE 
loses it and commits with the endodermal fate.  Following segregation of PE, the 
epiblast of the late blastocyst (embryonic day 4.0) acquires a pluripotency state 
known as “naive” or “ground state” (Hackett and Surani, 2014). The naive state 
pluripotent epiblast is functionally and molecularly different from blastomeres and 
early inner cell mass (Gardner, 1998; Kurimoto et al., 2006; Kaji et al., 2007; Nichols 
and Smith, 2009). The naive state is characterized by homogenous expression of key 
pluripotency transcription factors and by the elimination of gametic epigenetic 
silencing, which results in a generalized hypomethylated “open” chromatin state, 
including both X-chromosomes in female embryos. The “naive state” is therefore 
considered as the unrestricted pluripotent state in which cells show an unbiased 
developmental potential.  
 
Departure from the naive status starts in the epiblast shortly after 
implantation; however, pluripotency is maintained for several days before 
differentiation starts during gastrulation (E6.5). The transit between naive-state 
epiblast cells takes place in a continuum manner in which cells transit through a 




with a particular fate and differentiate (Nichols and Smith, 2009; Hackett and 
Surani, 2014; Kalkan et al., 2017).  
 
In addition, both states are characterized by expressing the core pluripotency 
network. Initially this regulatory network was almost exclusively referred to a small 
set of transcription factors, Oct4, Sox2 and Nanog (Orkin, 2005). These three factors 
converge and form the primary, yet central, network that governs the robust 
pluripotent state. On one hand, Oct4 is essential for early mouse development and 
maintenance of the ES cell pluripotency (Nichols et al., 1998). On the other hand, 
Sox2 is generally considered a transcriptional partner of Oct4 (Avilion et al., 2003). 
And finally, the presence of Nanog in tissue culture relieves the requirement for LIF 
by promoting ES cell self-renewal (Chambers et al., 2003; Mitsui et al., 2003). In 
spite of the relevance of these key transcription factors and their cooperative 
autoregulation to maintain ESCs properties, some studies also point to the 
involvement of additional factors that either provide feed-forward regulations to 
stabilize the pluripotency network, or exert other cellular functions required for ESC 
identity maintenance (Ivanova et al., 2006; Wang et al., 2006; Zhou et al., 2007). 
 
2.3. Naive and Primed stem cell pluripotent states in culture 
 
The different types of pluripotency observed in vivo can be captured in 
apparently equivalent states in cultured cells. The transient nature of naive 
pluripotency is captured in vitro in ESCs derived from the ICM or through 
experimental reprogramming (Evans and Kaufman, 1981; Martin, 1981; Yamanaka 
and Blau, 2010; Hackett and Surani, 2014) (Figure 6). ESCs represent a surrogate in 
vitro model of the naive epiblast status that, under permissive culture conditions, 
keeps naive pluripotent capacity while undergoing self-renewal. On the other hand, 
both in vitro models of epiblast stem cells (EpiSCs) derived from late epiblast (Brons 
et al., 2007; Tesar et al., 2007) and epiblast-like cells (EpiLCs), which are derived 
from ESCs showing a cellular state highly similar to pregastrulating epiblasts but 
distinct from EpiSCs (Hayashi et al., 2011), capture the primed pluripotent state 






The definition of both states implies that the naive ESCs correspond to a more 
immature state of pluripotency whereas the primed state is prone to differentiate, 
which is reflected, for example, in the state of X-chromosome inactivation. In naive 
female cells, both chromosomes are active; on the contrary, primed EpiSCs have 
already undergone X-chromosome inactivation (Hanna et al., 2010). 
 
Furthermore, the two pluripotent states exhibit distinct molecular signatures 
and in vitro growth properties (Figure 7). In addition, the two states depend on 
signalling pathways that often antagonize each other (Hanna et al., 2010). Although 
the core pluripotency network is expressed in both naive and differentiating-primed 
states (Wang et al., 2006), they differ in the signalling pathway they rely on (Figure 
7). The BMP/SMAD signalling pathway (Ying et al., 2003) and LIF/STAT3 (Smith et 
al., 1988) maintain naive pluripotency of ESCs, whereas FGF/MAPK promotes 
 
Figure 6. Scheme of different types of mouse pluripotent stem cells and 
their sources. 
 
Several pluripotent cell types can be derived by explanting cells at various stages of 
early mouse embryonic development. ESCs are derived from cells harvested at the 
blastocyst stage. Pluripotent cells derived from post-implantation embryo give rise to 
epiblast stem cells (EpiSCs). Embryonic germ cells and spermatogonial germ cells 
(GSC) are derived from primordial germ cells (PGCs) from embryos and 
spermatogonial progenitors from adults respectively.  Alternatively, somatic cells can 
be directly reprogrammed in vitro by exogenous expression of transcription factors 
generating induced pluripotent stem cells (iPSCs). In addition, epiblast-like cells 





transition to the primed state and, together with Activin/Nodal promote definitive 
differentiation (Brons et al., 2007; Tesar et al., 2007) (Figure 7). 
 
 Based on this knowledge, different culture conditions can promote the 
different states of pluripotency found in the embryo. Fetal bovine serum, together 
with mouse embryonic fibroblasts (MEFs), was originally used to derive ESCs 
(Martin and Evans, 1975). Serum contains BMP4, which is crucial for activating 
Inhibitor of Differentiation (Id) genes via SMAD pathway (Figure 7). Serum can be 
thus substituted by overexpression of Id genes or exogenous addition of BMP4 
(Hackett and Surani, 2014). However, serum contains as well FGF and activin-like 
activities that promote exit from the ground state and differentiation and MEFs were 
important in limiting this differentiation promotion. LIF, which activates the JAK-
STAT3 signalling pathway (Figure 7), was later reported to be essential for enabling 
the proliferation of ESCs without MEFs (Smith et al., 1988; Williams et al., 1988).  
 
Maintenance of naive pluripotency can be achieved by serum/LIF culture 
conditions. However, in these conventional conditions self-renewal is maintained by 
abrogation or counterbalance of differentiation stimuli downstream of their effects. 
Therefore, in serum/LIF ESCs exist in a battleground of competing signals and 
exhibit heterogeneous expression of pluripotency markers that gives rise to 
metastability. In fact, only a fraction of these cells correlate with the pre-implantation 
epiblast, as shown by transcriptional and epigenetic profiling (Ying et al., 2008; 
Marks et al., 2012; Boroviak et al., 2014). 
 
It is thus preferable to insulate, rather than counteract, differentiation stimuli 
in order to stabilize upstream naive state. Two inhibitor (2i) molecules have been 
found sufficient to protect ESCs from differentiation stimuli and select against 
differentiating cells. PD03 (PD0325901) inhibits FGF/ERK signalling pathway by 
blocking ERK1/2 phosphorylation (Ying et al., 2008), which appears to drive 
transition from naive to primed state (Kunath et al., 2007) (Figure 7). In the presence 
of PD03 LIF is still required to support ESC naive and self-renewing state. GSK3 
inhibition enhances ESC self-renewal (Sato et al., 2004; Ogawa et al., 2006), and the 
inclusion of the GSK3 inhibitor, CHIRON (CHIR99021)  (Figure 7) in addition to 




serum/BMP4 (Ying et al., 2008). Collectively PD03 and CHIRON inhibitors are 
known as the “2i” culture system. In 2i/LIF cultures most of ESCs exhibit molecular 
and functional properties corresponding to an optimized state of naive pluripotency 
that is closely comparable to the developmental ground state in vivo. Therefore, ESCs 
in 2i cultures retain the essential features of early epiblast pluripotent cells (Boroviak 






Additionally, investigation about pluripotency has been enhanced after the 
discovery of cell reprogramming by forced expression of a set of transcription factors, 
which also provided an enormous potential for regenerative medicine. Previous 
studies show that somatic cells can be reprogrammed by transferring their nuclear 
contents into oocytes (Wilmut et al., 1997) or by fusion with ESCs (Tada et al., 2001; 
Cowan et al., 2005) indicating that unfertilized eggs and ES cells contain factors that 
can confer totipotency or pluripotency to somatic cells. However, a later works 
demonstrated the flexibility of cellular identity by the full reprogramming of 
differentiated somatic cells to pluripotent stem cells through forced expression of a 
set of transcription factors. These new generated pluripotent cells are called induced 
pluripotent stem cells (iPSCs) (Takahashi and Yamanaka, 2006). The initial genes 
identified as responsible for reprograming adult cells are Oct3/4, Sox2, Klf4 and Myc 







Figure 7. Schematic of the main extrinsic signalling pathways that 
determine the naive and primed pluripotent states. 
 
Naive and primed mouse pluripotent stem cells can be positively or negatively 
regulated by different signalling pathways.  LIF mainly acts phosphorylating STAT3 via 
JAK, which activates Tfcp2l1 and Klf4 reinforcing the pluripotency network. When cells 
are grown with serum, BMP4 is present in the medium and functions via SMADs to 
activate Id genes blocking the differentiation networks. When 2i medium is used to 
culture cells, CHIRON acts via GSK3 inhibition, mimicking canonical WNT signalling. 
GSK3 blockade leads to b-catenin stabilization, which abrogates TCF3-mediated 
repression of pluripotency genes, including Esrrb. PD03 blocks MEK activity of the 
FGF signalling cascade. FGF activates the MAPK pathway leading to MEK 
phosphorylation that phosphorylates and activates ERK. The active form of ERK 
promotes transition to a primed state. Filled arrows indicate activation, whereas bars 
mean inhibition or blockade of target activity. Dashed lines show an indirect or 
deduced effect and a solid line indicates a direct or known downstream target. (Based 





3. The proto-oncogene Myc family in development 
 
3.1. Functions of the transcription factors of the Myc family in 
mammalian development 
 
During the last decades, the role of the proto-oncogene Myc gene family 
(comprising 3 transcription factors: Myc, Mycn and Mycl) in normal and cancer cells 
has been extensively studied. The fact that Myc genes are deregulated in most 
tumours has attracted attention across the cancer research field. Nevertheless, in this 
thesis we are interested in non-oncogenic roles of this family in normal development, 
pluripotency and cell competition. The three main members of the proto-oncogenic 
Myc family are involved in several cellular processes, such as the regulation of cellular 
proliferation, differentiation and apoptosis (Meyer and Penn, 2008). The role of Myc 
proteins in development has been intensively investigated. Even though Mycl is 
widely expressed in the mouse embryo, it appears not to be necessary for embryonic 
development, as Mycl knockout mice develop normally (Hatton et al., 1996). 
Contrary to this, Myc deficient embryos die before E10.5 due to hematopoietic and 
placental defects (Trumpp et al., 2001; Dubois et al., 2008) and embryos lacking 
Mycn are die at E11.5 exhibiting neuroectodermal and heart defects (Charron et al., 
1992), indicating that endogenous Myc and Mycn are critical for completing 
embryogenesis. However, they have also been shown to be separately dispensable for 
murine embryonic stem cell function. The lack of phenotype of the single KOs 
suggests highly redundant functions of Myc and Mycn (Malynn et al., 2000). 
Moreover, recently it has been shown that Myc and Mycn cooperate in maintaining 
the ESC proliferative program (Scognamiglio et al., 2016). 
 
3.2. Myc factors and pluripotency  
 
Myc has been reported to regulate cell cycle regulation, cell growth and 
metabolism in ESC, by regulating a different subset of genes than those targeted by 
the core pluripotency network transcription factors (Chen et al., 2008; Hu et al., 
2009; Kim et al., 2010; Claveria et al., 2013; Gu et al., 2016; Scognamiglio et al., 




2009). Myc also controls the balance between self-renewal and differentiation in 
adult hematopoietic stem cells (Wilson et al., 2004).  
 
Additionally, in ESCs cultured in serum plus LIF, Myc proteins have been 
suggested to sustain pluripotency through repression of the primitive endoderm 
master regulator GATA6 and contribute to the cell cycle control by regulating the 
mir-17-92 miRNA cluster (Smith et al., 2010). 
 
 Furthermore, Myc has been described to promote cell reprogramming of somatic 
cells into a naive pluripotent status in cooperation with transcription factors of the 
core pluripotency network, such as Oct4, Sox2 and Klf4 (Cartwright et al., 2005; 
Takahashi and Yamanaka, 2006). In addition, primed EpiSCs can also be reverted to 
the naive state by overexpressing Klf4 or Myc in EpiSCs under LIF-exposure 
conditions (Guo et al., 2009; Hanna et al., 2009). More recently, ESC self-renewal 
capacity has been reported to be maintained thanks to a Myc-dependent self-
propagating epigenetic memory, which is established by a Myc-driven positive feed-
back loop (Fagnocchi et al., 2016). 
 
Even though several studies have tried to shed light on the relationship 
between Myc and pluripotency and some roles have been reported both in vivo and in 
vitro, the precise role of Myc with respect to pluripotency states in embryos and 

















































In the field of Cell Competition, many studies have tried to shed light on how 
fitness comparison is produced between neighbouring cells and results in the 
elimination of the less fit cells. Natural cell-to-cell heterogeneity in Myc levels has 
been reported to trigger cell competition both in early mouse development and ESCs. 
In this thesis, we aimed to perform further studies to understand the dynamics of 
Myc-related endogenous cell competition and explore the biological relevance of this 
phenomenon during normal mouse development and ESC maintenance. 
 
The specific aims of this thesis were: 
 
Generate a new time-lapse microscopy and image analysis tool to track Myc 
levels during cell competition in ESCs. 
 
Determine the dynamics of Myc heterogeneity and how it is regulated in 
pluripotent cells. 
 
Determine how the cell-to-cell Myc heterogeneous levels lead to cell 
competition and the dynamics of Myc expression during the process. 
 
Determine the biological basis of Myc-driven endogenous cell competition in 
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1. Mouse lines and mESC derived lines 
 
The iMOSWT, iMOST1-Myc and iMOST2-p35 mouse lines have been previously 
described (Claveria et al., 2013). After recombination both labelled populations are 
WT in the iMOSWT cell line. In the iMOST1-Myc the EYFP population overexpresses 
Myc and ECFP cells are WT. In the iMOST2-p35 the EYFP population is WT and the 
ECFP population expresses the baculoviral apoptosis inhibitor p35.  
 
Sox2Cre mice (Hayashi et al., 2002) were used to activate the iMOST2-p35  line 
when the experiment was performed in embryos and to generate the Myc KO from 
the Mycflox/flox line. 
 
The GFP-Myc reporter line has been previously described (Huang et al., 
2008).  Homozygous mice are viable and show no apparent phenotypic alterations.   
 
WT mice used are of the CD1 strain. 
 
Mouse embryonic stem cells were derived from E3.5 embryos from the 
following mouse lines: iMOSWT, iMOST1-Myc, iMOST2-p35 and GFP-Myc. The protocol 
for establishing ESC lines is explained below.  
 
2. E5-6 embryo harvest 
 
Mice embryos were extracted at different developmental stages. Vaginal plugs 
were checked every morning. Midday of the day when vaginal plug is detected is 
considered gestational day 0.5 (E0.5). To obtain the embryos, females were sacrificed 
by CO2 inhalation and abdominal cavity was opened to expose the uterus, which was 
transferred to sterile PBS. Then working in cold PBS under the scope, muscular 
uterine wall was carefully ripped and then the decidual layer was removed. Exposed 
embryos were fixed in paraformaldehyde (PFA) (Merck) 2% in PBS overnight at 4ºC. 
After fixation embryos were washed in PBS several times. 
 
 
MATERIALS	  AND	  METHODS	  
	  
 64 
3. Mouse embryonic fibroblasts culture 
 
Mouse embryonic fibroblasts (MEFs) were only used as a feeder layer for the 
stem cells. Fibroblasts have been previously extracted from E10.5 embryos by the 
Pluripotent Cell Technology Unit staff. Approximately 5 million of cells from one vial 
were plated on 100-mm 0.1% gelatine-coated plastic plates (Falcon). After 2 days 
cells were passed to 2 150-mm 0.1% gelatine-coated plastic plates (Falcon) and 
cultured again for another 2 days. Fibroblasts were then inactivated with mitoMycin-
C (Sigma), trypsinized (Trypsin-EDTA 10x, Gibco) and frozen. MEF culture medium 
contained the following reagents: 
 
o   High glucose DMEM, GlutaMAX™ Pyruvate (LifeTech) 
o   15% Fetal Bovine Serum (FBS) 
o   1% Penicillin/Streptomycin (10,000U/ml; 100x) 
o   0,2% 2-beta-mercaptoethanol (50mM) 
 
MEFs freezing medium contained: 
 
o   60% MEF culture medium 
o   20% FBS 
o   20% DMSO (Sigma) 
 
4. Mouse ESC derivation and establishment 
 
Mouse ESCs were derived from E3.5 embryos. Female sacrifice and uterus 
extraction was done as described. Embryos extraction was performed by flushing the 
blastocysts out of the uterus under a dissection scope using a 1-ml syringe with 23-G 
needle. Blastocysts were collected and transferred individually to wells of a 24-well 
plate (Falcon) containing fresh mitoMycin-C-inactivated MEF feeder layer. Culture 
was maintained for 5-8 days in 2i (GSK3β and Mek 1/2 inhibitors) medium. Medium 
was not changed until the blastocysts attached, then it was changed every day. Those 
hatching blastocysts whose inner cell mass expanded were properly trypsinized and 
seeded on a well of 12-well plate (Falcon) and then went through several passages in 
order to expand the clone. 




2i derivation medium contained: 
 
o   High glucose DMEM, GlutaMAX™ Pyruvate (LifeTech) 
o   15% KO-Serum Replacement (Invitrogen) 
o   Leukemia Inhibitor Factor (LIF) 
o   1% nonessential amino acids (100x) 
o   1% Penicillin/Streptomycin (10,000U/ml; 100x) 
o   0.3 µM GSK3β inhibitor CHIR99021 (Stemolecule™) 
o   0.1 µM Mek 1/2 inhibitor PD0325901 (Stemolecule™) 
 
Cultures were checked for Mycoplasma by the Cell Culture Unit staff and for 
normal karyotype (protocol explained below) at their establishment.  
 
For time-lapse studies, the ESC lines were stably transfected with a PGK-





Approximately 1,5x106 cells in a p-60mm plate (Falcon) were treated with 
0,5µg/ml colcemid (KARYO MAX COLCEMID, Gibco) for 1 hour at 37ºC.  Cells were 
then trypsinized and resuspended in 6 ml of a hypotonic solution (75mM KCl) for 7 
minutes at room temperature. 8 drops of a fixative solution (3:1 methanol/glacial 
acetic acid) were added and then centrifuged for 5 minutes at 900rpm at room 
temperature. Supernatant was removed and 6ml of the fixative solution were added 
again, letting 20 minutes in ice. This last step was repeated twice. Finally, a small 
volume of the solution was dropped on a slice, dried and mounted with DAPI. 
Karyotype of a cell line was considered suitable when more than 80% of the cells 
exhibited normal karyotype.  
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5. Mouse ESC routine culture 
 
ESCs were routinely maintained on mitoMycin-C-inactivated MEF feeder 
layers. Cells were passed every 2 days and frozen 800,000-900,000 cells per vial. 
ESC routine culture medium (SR-ES medium) contained the following reagents: 
 
o   High glucose DMEM, GlutaMAX™ Pyruvate (LifeTech) 
o   15% KO-Serum Replacement (Invitrogen) 
o   Leukemia Inhibitor Factor (LIF) 
o   1% nonessential amino acids (100x) 
o   0,1% 2-beta-mercaptoethanol (50mM) 
 
mESCs freezing medium contained: 
 
o   60% ESC culture medium 
o   20% FBS 
o   20% DMSO (Sigma) 
 
6. iMOS induction for functional assays in ESCs 
 
For the iMOST1-Myc and iMOST2-p35 induction, cells were plated without feeder 
on fibronectin-coated 3.5-mm glass bottom dishes (MatTek) and cultured in 2xLIF 
SR-ES medium. After 24h iMOST1-Myc cells were treated with 10 µM 4-
hydroxytamoxifen (4-OHTAM) (Sigma-Aldrich) and iMOST2-p35 cells with 20 µM for 




7.1 Whole mount embryo immunofluorescence 
 
For E5-E6.5 embryos, same procedure was followed for all the stainings. 
Embryos were permeabilized in 0.5% Triton X-100 (Calbiochem) for 30 minutes. 
Excess of triton was washed in PBS during 15 minutes. Blocking was performed in 
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10% goat serum (Gibco-BRL Life-Technologies) 0.1% Triton X-100 for one hour and 
then incubation with the primary antibodies was performed overnight at 4ºC. 
Embryos were washed several times and incubated with secondary antibodies and 
DAPI (1:2000) overnight at 4ºC. Following day and after several washes, embryos 
were ready to be imaged and store in PBS or Vectashield mounting medium (Vector 
Laboratories, USA). Primary and the secondary antibodies were diluted in the 
blocking solution.  
 
7.2. Mouse ESC immunofluorescence 
 
For mouse ESCs the same protocol was followed for all the stainings, excepting 
for pSTAT3 immunofluorescence. Fixed samples were permeabilized in 0.25% Triton 
X-100 (Calbiochem) from 10 to 30 minutes depending on the antibody, washed in 
PBS and blocked with 10% goat serum 0.1% Triton X-100 for one hour. Incubation 
with the primary antibodies was performed at room temperature for one hour. After 
several washes, secondary antibodies and DAPI (1:2000) were incubated during 1 
hour at room temperature. Cells were then washed and mounted in Vectashield 
mounting medium.  
 
For pSTAT3 staining, cells were permeabilized in cold 100% methanol for 10 
minutes at -20ºC and the blocking solution contains 5% goat serum in 0.25% Triton 
X-100. Primary and the secondary antibodies were diluted in the blocking buffer. 
 
7.3. Primary antibodies  
 
o   anti-Myc polyclonal antibody (06-340, Millipore) 1:300 
o   anti-Myc T58 (ab85380, abcam) 
o   phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (#4370, Cell Signaling) 
1:200 
o   anti-phospho-histone H3 (Ser 10) ‘mitosis marker’ (06-570, Millipore) 
1:300 
o   Phospho-Histone H3 (Ser10) (6G3) (#9706, Cell Signaling) 1:300 
o   cleaved-caspase3 (Asp175) Antibody (#9661 Cell Signaling) 1:100 
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o   phospho-Stat3 (Tyr705) D3A7 (#9145, Cell Signaling) 1:100 
o   anti-GFP (GFP-1010; Aves Lab) 1:500 
o   phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (#9106 or #4370, Cell 
Signaling) 1:200 
o   Mycn (NCM II 100; sc-56729, Santa Cruz) 1:100 
o   Anti-mouse Nanog purified (14-5761-80, eBioscience) 1:200 
 
7.4. Secondary antibodies  
 
All of them were used 1:500. 
 
o   488 goat anti-rabbit (Life Tech) 
o   488 goat anti-mouse (Life Tech) 
o   Cy3 goat anti-rabbit (Jackson) 
o   568 goat anti-mouse (Life Tech) 
o   568 goat anti-chicken (Life Tech) 
o   633 goat anti-rabbit (Life Tech) 
o   633 goat anti-mouse (Life Tech) 
o   647 donkey anti-chicken (Jackson) 
 
8. Confocal microscopy 
 
Immunofluorescence of fixed cells was imaged with either a Leica TCS SP5 
inverted conventional confocal microscope fitted with a HCX PL APO CS 40x 1.25 oil 
objective, an SP8 inverted conventional confocal microscope fitted with HC PL Apo 
CS2 40x/1.3 oil objective, or a Zeiss LSM 780 upright microscope fitted with W Plan-
Apochromat 40x/1,0 DIC M27 objective. Whole mouse embryos were imaged with a 
Zeiss LSM 780 upright microscope fitted with a W Plan-Apochromat 20x/1,0 DIC 
M27 75mm WD 1.8mm objective in confocal mode at 405, 488, 568 or 663 nm. Z-
stacks were acquired in order to image the whole embryo. Acquisitions were 
commonly 1024x1024 pixels, A.U. set to 1.5.  
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9. Time-lapse video microscopy of ESC cultures  
 
200,000 GFP-Myc ESCs were seeded on 3.5-mm 0.1% gelatine-coated plastic 
plates (Falcon) without feeder and cultured in 2xLIF SR-ES medium. 24 h later cells 
were transferred to the environmental chamber of a Zeiss LSM 780 upright 
microscope. In every imaging experiment, the incubation chamber was previously 
stabilized to 37ºC and 5% CO2 by mixing and humidification. To avoid liquid 
evaporation, embryo-grade mineral oil was added on top of the medium after 
objective immersion. Samples were imaged with a W Plan-Apochromat 40x/1,0 DIC 
M27 objective every 7 minutes for 24 h. Z-stacks with sections spaced at 2 µm are 
acquired at each timepoint. In addition, a multi-position map was generated, and 
every ESC colony was manually assigned an x-y-z location. We used confocal lasers 
with two excitation channels (488 nm excitation for GFP-Myc visualization and 
561 nm excitation for the tdTomato membrane marker), and all images were 512x512 
pixels (0.415x0.415 µm resolution), taken at speed 7 and with 2 scans/Z-slice. A 
trade-off between spatial resolution, temporal resolution and total acquisition time 
was carefully selected to minimize photobleaching while enabling tracking of cell 
division, apoptosis and cell-cell interactions. For apoptosis detection, we added either 
Hoechst33258 (B-2883, Sigma) (1:2000) or caspase3-reporter (CaspGLOWTM Red 
Caspase Staining kit, MBL) (1:1000) to the medium immediately before imaging. 
 
For iMOST1-Myc induction analysis, we started time-lapse confocal analysis 10 h 
after the induction. The timings of new EYFP+ cells and apoptotic events were scored 
manually. 
 
In the GFP-Myc and iMOST1-Myc coculture, both populations were seeded in a 
proportion 1:1. The timings of new EYFP+ cells and apoptotic events were scored 
manually. 
 
10. Clonal analysis assay 
 
150,000 ESCs were plated without feeder on fibronectin-coated 3.5-mm glass 
bottom dishes (MatTek) and cultured in 2xLIF SR-ES medium. To generate clones we 
used the iMOSWT cell line (Claveria et al., 2013) and induced EYFP clones at a very 
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low recombination rate. For this, cells were treated 48h after plating for 1 h with 5 µM 
4-hydroxytamoxifen (4-OHTAM) (Sigma-Aldrich) and cultured for an additional 
60h. Only 15% of colonies were recombined, so the expected frequency of polyclonal 
groups was around 2% (0.152X100). Cells were fixed and analyzed by confocal 
immunofluorescence for Myc, and subject to confocal analysis. We then calculated 
the variation of Myc levels within clonal groups identified by EYFP signal and for a 
set of equivalent randomly chosen cell groups. We repeated the process at least 100 
times per colony to have a sample representative of the whole population and 
considered the median standard deviation of the 100 subsamples. 
 
11. Flow Citometry 
 
For cell cycle analysis, cells were trypsinized, incubated in culture medium 
with 5 µg/ml Hoechst33342 (B2261-Sigma) for 45 minutes at 37ºC, washed and 
resuspended in 2% FBS PBS and analysed by flow cytometry in a BD FACSCanto™ II 
(laser wavelengths 405, 488, 561, 640). Propidium iodide (P4864-Sigma) was used to 
identify dead cells.  
 
For the DNA demethylation experiments, 5-Azacytidine was previously 
dissolved at 20.5 mM in water:acid acetic (1:1) and cells were treated with 0,25 µM 5-
Azacytidine (A2385, Sigma).  After treatment cells were washed, trypsinized, 
resuspended in 2% FBS PBS and stained with Hoechst33258 (B-2883, Sigma) for 
dead cell exclusion. Cell suspensions were analysed in a BD LSRFortessa™ Special 
Order Research Product (laser wavelengths 405, 488). 
 
For the LIF withdrawal assay, cells were trypsinized, resuspended in 2% FBS 
PBS and stained with Hoechst33258 (B-2883, Sigma) for dead cell exclusion. Cell 
suspensions were analysed in a BD LSRFortessa™ Special Order Research Product 
(laser wavelengths 405, 488, 561). 
 
For the analysis, FACSDiva and FlowJo softwares were used. 
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12. RNA isolation from cells 
 
In order to perform RNA differential expression analysis, RNA from cells was 
isolated. For assess the difference in gene expression depending on Myc levels, total 
RNA was purified from GFP-Myc ES cells sorted in BD FACSAria™ II flow cytometer 
according to GFP-Myc (three biological replicas). RNA was extracted using RNeasy 
Mini Kit (Qiagen). Isolated RNA was then handed to Genomic Unit in CNIC to 
proceed with sequencing. 
 
13. RNASeq. Data analysis 
	  
13.1. RNAseq library production 
 
In order to assess the difference in gene expression among the three 
populations depending on Myc levels, total RNA was purified from ES cells sorted in 
a cytometer according to GFP-Myc (three biological replicas). A cDNA library was 
prepared according to Illumina recommendations and sequenced in a GAII analyzer 
using the paired-end 50bp protocol. Sequencing reads were pre-processed by means 
of a pipeline that used FastQC to asses read quality, and Cutadapt v1.3 (Martin, 2011) 
to trim sequencing reads, eliminating Illumina adaptor remains and discarding reads 
shorter than 30 bp. Reads were mapped against the mouse transcriptome (GRCm38 
assembly, Ensembl release 76) and quantified using RSEM v1.2.3 (Li and Dewey, 
2011).Raw data have been deposited in the GEO database with reference number 
GSE89196 .Raw expression counts were then processed with an analysis pipeline that 
used the Bioconductor package EdgeR (Robinson et al., 2010) for normalization and 
differential expression testing. Only genes expressed at a minimal level of 1 count per 
million, in at least 3 samples, were considered for differential expression analysis.  
 
13.2. RNAseq meta-analysis 
 
Gene set enrichment analysis was performed using the online tools in the 
Broad Institute GSEA web site (http://software.broadinstitute.org/gsea/). Genes 
with significant variation between Myc-H and Myc-L cells (adj pval <0.001) were 
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screened against the curated “chemical and genetic perturbations” database. 8 of the 
top-ten hits corresponding to experiments in embryonic stem cells were gene sets 
identifying targets of pluripotency factors (p-values between <3.78-25 and <1,73-62).  
 
For Principal Components Analysis, we compared our RNA-seq dataset to 
Gene Expression Omnibus RNA-Seq datasets GSE67259 and GSE56138. For 
GSE67259 dataset, expression levels in RPMs were compared with the TPMs 
calculated from FPKMs of dataset GSE56138 and to the TPMs of our dataset. For 
each gene symbol, we considered the TPMs of all samples from all datasets. 16,998 
genes were expressed in all experiments. Combat (Robinson et al., 2010) without 
covariate was then used on the log2-TPMs matrix to remove batch differences among 
the datasets. ggfortify and gplots packages were used for visualization of the Principal 
Components Analysis and main gene set contributing to the Principal Component 1.   
 
14. Image analysis 
	  
14.1. Nuclear and cytoplasmic signal detection 
  
Confocal images were analyzed with ImageJ (http://imagej.nih.gov/ij). To 
quantify nuclear signal, nuclei were detected by DAPI staining and segmented by 
using threshold tool to create a mask. Manual correction was applied to ensure the 
segmented objects belonged to individual cells. Masks were applied to the 
corresponding channel and a measure tool gave the mean intensity for every single 
object.  For cytoplasm signal quantification masks were obtained by subtracting DAPI 
mask to the whole cell mask, which was created thanks to Tomato membrane marker. 
Signal intensity measuring was performed as in the nuclei.  
 
14.2. Video editing 
 
Time-lapse videos were edited using Imaris x64 sotware. Imaris allowed to 
generate a video file from lsm format files (Zen lite files from Zeiss microscopy).  
Videos were re-edited with Adobe After Effects software. 
 




14.3. 4D tracking workflow 
 
Image processing and analysis methods were developed using Definiens 
Developer version XD2.4 (Definiens AG, Germany) and Matlab (R2015a, 
Bioinformatics, Image Processing, Optimization, Statistics and Machine Learning 
toolboxes). A manual-editing tool was implemented, allowing the user to visualize 
and correct errors. Quantitative cellular parameters in the pipeline are automatically 
extracted from the segmented and tracked nuclei, generating tables ready for data 
mining. The tables contain information on cell and nuclear position and shape, 
nuclear GFP intensity, cell neighbourhood, nuclear size, mitosis and apoptosis. The 
complete set of primary data generated is in Table 1. 
 
During time-lapse analysis, photobleaching of GFP-Myc fluorescence 
produced a progressive signal reduction throughout the first third of the tracking 
period (Figure 8). After the initial photobleaching, the GFP-Myc signal was stable 
during the remainder of the tracking period (Figure 8). To avoid interference from 
photobleaching during the analysis, we used established methods (Gopinath et al., 
2008) to normalize the values, using the endpoint mean and standard deviation as 
reference values. All quantitative analyses were made using the normalized data.  
This procedure allowed to perform meaningful in silico synchronizations. 
 
 
Figure 8. Correction of GFP-Myc 
signal after photo-bleaching. 
 
Graph displays individual data (dots) and 
locally weighted scatterplot smooth lines 
showing raw and corrected GFP-Myc 
levels of all recorded data synchronized to 
the start of time-lapse analysis. 
	  




15. Statistical analysis  
 
Comparisons and graphs were made with either GraphPad Prism 5.0a or NCSS 


















































1. Myc is the main driver of spontaneous cell competition in ESCs 
 
Myc has been reported to be involved in natural cell competition in the 
epiblast and ESCs (Claveria et al., 2013). Nevertheless, taking into account the 
similar regulation and cooperation in development and ESCs between Myc and Mycn 
(Malynn et al., 2000; Scognamiglio et al., 2016), we also wanted to explore the 
implication of Mycn in this phenomenon. 
 
It has been shown that Mycn can largely replace most Myc functions necessary 
for normal murine growth and development (Malynn et al., 2000). We thus explored 
whether Mycn could be compensating for Myc in ES cells. To address this, we first 
analysed the correlation between Myc and Mycn endogenous expression levels 
(Figure 9 A). Interestingly, in similarity to Myc, Mycn expression also showed a 
heterogeneous pattern in ESC cultures (Figure 9 A). However, quantification of both 
Myc and Mycn did not show any negative or positive significant correlation between 
both signals (Figure 9 A, B). This suggests that Mycn does not depend on Myc activity 
or undergoes compensatory regulation depending on Myc levels in ESCs. 
 
Engulfing of loser cells by neighbouring winner cells has been observed in 
mESC and epiblast cells (Claveria et al., 2013). It has been reported that in these 
winner-loser pairs Myc expression levels are much higher in the winner than in the 
loser cells (Claveria et al., 2013). To directly assess the implication of Mycn in cell 
competition, we then analysed Mycn expression in pairs of engulfing/engulfed cells 
(Figure 9 C). Quantification of Mycn levels of engulfing and engulfed cells showed no 
differences between them in Mycn expression levels (Figure 9 C, D).  
 
Given that not always cell competition involves engulfing events, we also 
examined caspase3-positive cells for Mycn levels (Figure 10 A). In WT cultures, Myc 
levels of apoptotic cells were reduced by half in comparison with Myc levels of non-
apoptotic cells (Figure 10 B), as already shown in previous works (Claveria et al., 
2013). On the contrary, Mycn levels did not show any difference between the 
apoptotic and non-apoptotic population (Figure 10 C). These data suggest that Mycn 






Figure 9. Mycn expression pattern and its implication in cell competition. 
 
A. Co-localization of Myc and Mycn in ESCs. B. Quantification of the correlation 
between Myc and Mycn immunofluorescence in single cells of ESC cultures. C. DAPI 
staining of an ESC colony; The magnified frame shows an engulfing event and Mycn 
immunofluorescence. D. Mycn level paired ratios in engulfing and engulfed ES cells in 
WT culture. Dotplot in D shows mean and standard error of the mean (SEM) and one 






These observations suggest that, even though endogenous Mycn is not 
homogeneously expressed in ESCs, the differences in Mycn levels between cells are 
not determinant in spontaneous cell competition in ESCs. Myc is thus the only factor 




Figure 10. Study of Mycn role in apoptotic-mediated cell competition.  
 
A. Confocal detection of caspase-3, Myc and Mycn immunofluorescence in an ESC 
colony. B. Myc levels in non-apoptotic (general population) and apoptotic (caspase-3 
positive) cells. C. Mycn levels in non-apoptotic (general population) and apoptotic 
(caspase-3 positive) cells. Boxplots in B and C show median, 25 and 75 percentiles 
(boxes), 10 and 90 percentiles (whiskers). Mann Whitney test was used for statistics. 





2. Live imaging analysis of Myc levels in mESCs 
	  
2.1. The GFP-Myc knock-in line faithfully reports endogenous Myc 
expression 
 
Although the implication of Myc in cell metabolism and proliferation in ESCs 
(Hu et al., 2009; Kim et al., 2010; Claveria et al., 2013; Gu et al., 2016; Scognamiglio 
et al., 2016) and cell reprogramming (Cartwright et al., 2005; Takahashi and 
Yamanaka, 2006) has been studied, the biological basis and dynamics of Myc-
mediated cell competition remains elusive.  To address this question, we used live 
reporting and tracking of endogenous Myc levels in mouse pluripotent cells. As a tool 
for this we derived a homozygous ESC line from previously described knock-in mice 
expressing a GFP-Myc fusion protein from the Myc locus (Huang et al., 2008) (see 
Material and Methods).  
 
In the first place, as Myc protein (Cartwright et al., 2005) and mRNA (Dani et 
al., 1984; Hann and Eisenman, 1984) have very short half-lives, we wanted to 
determine the reliability of this GFP-Myc knock-in line in reporting endogenous Myc 
levels. To this end, we studied the mouse embryo epiblast and found that GFP-Myc 
faithfully reported Myc levels in this tissue, despite the cell-to-cell highly 
heterogeneous Myc pattern (Claveria et al., 2013) (Figure 11 A, B). In addition, in 
ESCs we also found a strong and fast variation of Myc during mitosis (Figure 11 C). 
Both Myc, detected by immunofluorescence, and GFP-Myc levels showed a drastic 
decreased in the transition from prophase to metaphase and a sharped increase 
during late telophase, being almost undetectable during metaphase, anaphase and 
cytokinesis (Figure 11 C, D). Moreover, we observed that this decrease during mitosis 
matches an increase in T58-phosphorylation (Figure 11 D), which targets Myc for 
degradation (Welcker et al., 2004). During interphase, T58-phosphorylated Myc was 
not detected, which indicates that Myc is specifically degraded during mitosis. These 
results demonstrated that the GFP-Myc knock-in line is a reliable reporter for 
endogenous Myc expression, even when the protein is rapidly degraded and re-








2.1. Setting up 24h 3D+t time-lapse and computer workflow for 
analysis 
 
In order to characterize Myc dynamics during endogenous cell competition we 
performed time-lapse experiments in which homozygous Myc-GFP cells were 
scanned in 3D during 24 hours. These 24h 3D+t time-lapses were then used to track 
all cells. As cells moved very actively in ESC colonies (video 1), 3D scans were 
acquired every 7 minutes in order to allow an accurate tracking (Figure 12 A). Nuclear 
GFP-Myc signal and tdTomato cell membrane marker were acquired with green 
(488nm) and red (555nm) channels respectively (Figure 12 B) in a Zeiss LSM 780 
upright microscope (see more details in Materials and Methods).  
 
Next, in collaboration with the Cellomics Unit from CNIC, we developed a 
computer workflow for automatically segmentation and tracking the 3D+t 
acquisitions (Video 2) (Fernández de Manuel et al, 2017). This software also allowed 
to inspect and correct manually any incorrect outcome from the automatic 
segmentation and tracking (Figure 12 C) (see more details in Materials and Methods). 
With this approach, we were able to track cells across cell division, generating lineage 
trees in which the information on the progenitor cell identity was incorporated to 
daughter cell identities (Figure 12 D, E; videos 2 and 3). In this way, we obtained not 
only lineage trees for every cell family in the analysed colonies, but also multiple 
quantitative parameters, such as nuclear volume, cell trajectories, shapes and their 
fluctuations, GFP-Myc levels and information on neighbour cells (Figure 12 E; Table 
1).  
 
Figure 11. GFP-Myc line faithfully reports endogenous Myc expression. 
 
A. Confocal detection (optical sections) of Myc immunofluorescence and GFP native 
fluorescence in an E6.5 mouse embryo carrying the GFP-Myc knock-in allele in 
heterozygosis. B. Quantification of the correlation between GFP and Myc 
immunofluorescence in single cells of the E6.5 epiblast. C. Confocal images showing 
detection of Myc protein and co-localization with Ph3 and DAPI in different phases of 
mitosis in WT cells. D. Similar data are presented for the GFP-Myc reporter with an 








Figure 12. Multiparametric 4-dimensional analysis of embryonic stem cells, 
including lineage analysis and tracking of endogenous Myc levels. 
 
A. Live confocal microscopy set-up. B. Example of 3D raw data acquisition from live 
GFP-Myc, membrane-Tomato ESCs (top) and whole volumes 3D rendering from these 
images (bottom). C. 3D segmentation of the nuclei of the ESC colony in A, with GFP-
Myc levels displayed as green brightness intensity. D. Example of the tracking of 
segmented nuclei during mitosis. E. Cell lineage tree deduced from the tracking data, 






3. Myc is mostly regulated by cell-intrinsic heritable features  
	  
3.1. Study of Myc stability along the tracking 
 
As it has been shown above and described in previous works (Claveria et al., 
2013), Myc is heterogeneously expressed both in ESCs and in the embryo. Therefore, 
we wanted to test what was the nature of this heterogeneity. We previously observed 
no detection of T58-phosphorylated Myc in ES cultures (excepting mitotic cells) 
(Figure 11 D), discarding any implication of Myc degradation in driving Myc 
heterogeneity.  
 
We then determined the stability of Myc levels in the tracked cells. 
Classification of the whole cell population into three groups according to mean GFP-
Myc level (top 30%, Myc-high (H); lower 30%, Myc-low (L); the rest, Myc-medium 
(M)) showed that Myc-H cells have 2.5X higher GFP-Myc intensity than Myc-L cells 
(Figure 13 A). Next, we performed in silico synchronisation of the cell cycle in order 
to determine the fluctuations of Myc during cell cycle. The resulting expression 
profile captured the drastic reduction of GFP-Myc levels during mitosis and the rapid 
recovery during telophase (Figure 13 B; Figure 11 C, D). In addition, mitosis was 
preceded by a moderate increase in Myc levels, and typical fluctuations were detected 
afterwards (Figure 13 B). However, the severe fluctuations during mitosis did not 
extend enough time to explain the cell-to-cell heterogeneity observed in GFP-Myc 
levels (Figure 13 A).  
 
Next, we examined the stability of Myc-levels within the three groups 
previously established. During 24h tracking these groups revealed little variation 
(Figure 13 C). Interestingly, even after in silico synchronization, Myc levels were 
maintained through cell division, despite rapid Myc degradation and resynthesis 
(Figure 13 D). The fact that Myc levels are maintained through mitosis suggests that 





3.2. Retrospective clonal analysis of Myc 
 
Since from the time-lapse experiments we only have information of 24-hour 
periods, we decided to perform retrospective clonal analysis in ESCs. We used the 
iMOSWT  cell line (Claveria et al., 2013)  to generate EYFP+ clonal cell marks by 
inducing recombination at very low rate (see Materials and Methods for further 
 
Figure 13. Myc is to some extent imprinted in ESC lineages. 
 
A. Distribution of GFP-Myc levels after in silico classification of ESCs into groups 
according to live-recorded average GFP-Myc levels before cell’s first division. B. Display 
of individual (dots) and spline smooth line (SSL) of GFP-Myc levels of all dividing cells 
in silico synchronized to cell division. C. Tracking of GFP-Myc levels (SSLs) in Myc-H, 
Myc-M and Myc-L ESCs during the observation period. D. Similar data to C, 
synchronized to cell division time. Boxplots show median, 25 and 75 percentiles 







details). Cells were cultured for additional 60 hours after 4-hydroxytamoxifen 
removal. We then determined the variability of Myc levels between clonal groups of 
cells and randomly chosen equivalent groups. We found that Myc levels showed 
much lower variation in clonally related cells than in randomly chosen cells, with an 
estimated heritability of 0.8 per cell division, indicating that Myc levels display high 
heritability (Figure 14 A, B). In contrast with the predominant regulation of Myc in 
somatic cells, in which extracellular signals such as nutrients, mitogens or growth 
factors are described to be the main regulators (Wierstra and Alves, 2008), the clonal 
analysis, together with the previous observations in time-lapse and the cell-to-cell 
heterogeneity in Myc levels, indicates that Myc is mostly regulated by some intrinsic 
heritable mechanism in ESCs. Thus, sub-families of Myc expression levels seem to 
coexist in ESC cultures and largely transmit their Myc levels to their progeny.  
 
This form of heterogeneity is thus different from that reported for other 
transcription factors, such as Nanog, which has been shown to be regulated by 
stochastic transitions from low to high states of Nanog expression (Chambers et al., 
 
Figure 14. Retrospective clonal analysis of Myc. 
 
A. Example of a clonal mark induced by iMOSWT activation in an ESC colony together 
with immunofluorescence detection of Myc levels. B. Variation of Myc levels in clonal 
groups and equivalent groups of randomly chosen cells. Boxplots show median, 25 and 
75 percentiles (boxes), 10 and 90 percentiles (whiskers). Mann Whitney test was used 






2007; Kalmar et al., 2009). Moreover, quantification of both Myc and Nanog 
expression in ES cells did not show any significant correlation between both 
transcription factors (Figure 15 A, B). 
 
4. Temporal integration in losers of discrepant Myc levels with 
neighbours leads to cell competition 
4.1. Identification and characterization of apoptotic cells 
 
To study how MYC heterogeneity leads to cell competition we performed 
neighbour analysis by manual inspection using the computer workflow. First, we 
tracked apoptosis events during the 24-hours time-lapse analysis, identifying 24 
apoptotic cells, that we called prospective-dying cells (PDC) (videos 4-6). Three of 
these apoptotic events were discarded from further analysis as they were considered 
Myc-independent death events. First, we analysed the average Myc-GFP level of 
 
Figure 15. Myc and Nanog expression do not correlate. 
 
A. Confocal detection of Myc and Nanog immunofluorescence in an ESC colony 
showing colonization of both signals. B. Quantification of the correlation between GFP 






PDCs during the observation time, finding that, in agreement with previous works of 
Myc-driven competition (Claveria et al., 2013; Sancho et al., 2013), it was lower than 
that of the non-dying cells (NDCs) (Figure 16 A) and that it approximately matched 
the level found in MYC-L cells (Figure 13 A). Moreover, PDCs showed persistently 
lower GFP-Myc levels than NDCs, as revealed by the temporal profile of GFP-Myc 
levels synchronized to the time of PDC death (Figure 16 B).  These results indicate 
that pre-existing low Myc levels correlate with the loser fate. Interestingly, this 
synchronization also revealed that PDCs show a tendency to reduce their Myc-GFP 
levels starting approximately 500 minutes before death (Figure 16 B). For 
comparison, we characterized a group of cells that showed similar Myc-GFP levels to 
those found in PDCs (Figure 16 C) but did not die during the tracking; this group was 
named Myc-L non-dying cells (ML-NDCs). These cells also showed continuously 
lower Myc-GFP levels than the general population during the observation time but 





4.2. Analysis of PDC neighbourhood 
 
We then performed neighbourhood analysis of the GFP-Myc expression 
profiles. NDCs showed a GFP-Myc profile similar to that of their neighbours (Figure 
17 A). In contrast, in PDC neighbours GFP-Myc levels are initially lower than those of 
the general population but rise from 800 minutes before loser death up to matching 
the levels in NDCs and maintain a plateau until the death event (Figure 17 B, E). The 
increase in PDC neighbours’ GFP-Myc levels therefore precedes the decline in PDC 
GFP-Myc levels (Figure 17 B). The difference in GFP-Myc levels between PDCs and 
their neighbours was thus exacerbated before the death event (Figure 17 D). 
Conversely, ML-NDCs neighbours did not show any increase in their GFP-Myc level 
profile and they stably maintained lower levels than NDCs (Figure 17 C). The contrast 
in GFP-Myc levels between ML-NDCs and their neighbours is therefore always below 
that preceding PDCs death (Figure 17 D). Furthermore, by synchronizing ML-NDCs 
neighbours to the timepoints in which their GFP-Myc levels increase to match those 
of the plateau preceding PCD death, we observed that ML-NDC neighbours did not 
experience any increase in their GFP-Myc levels extending longer than 500 minutes 
(Figure 17 F). These results suggest that Myc-low cells survive in ESC colonies as long 
as the discrepancy in Myc expression with their neighbours is moderate. However, 
 
Figure 16. Characterization of apoptotic cells. 
 
A. Distribution of GFP-Myc levels during 24h live analysis of prospective dying cells 
(PDCs) and non-dying cells (NDCs). B. Temporal evolution of GFP-Myc levels (spline 
smooth line, SSL) in PDCs and NDCs, synchronized to the time of cell disappearance 
(death for PDCs and division for NDCs). Significant decreases between consecutive 
100-minute sections are shown (arrowheads). C. Graph showing the distribution of 
GFP-Myc levels during 24h live analysis of non-dying cells (NDCs) and Myc-low non-
dying cells (ML-NDC). D. Temporal evolution of GFP-Myc levels (SSLs) in NDCs and 
ML-NDCs. Boxplots in A and C show median, 25 and 75 percentiles (boxes), 10 and 90 
percentiles (whiskers). Mann Whitney test was used for statistics, p-val<0.001***, 
<0.0001****. Statistical analysis in B and D were performed by comparing 100-minute 
sections between the represented data sets using a Mann Whitney test; pink areas 
between graph lines indicate p-values <0.0001****. Longitudinal changes of PDCs 
shown in A were studied using Mann Whitney test to determine significant changes 
between consecutive 100-minute sections centred at 50-minute sliding positions. 
Transitions between consecutive temporal sections showing significant differences are 






sustained high discrepancies for periods above 600-800 minutes lead to their 
elimination.  
 
Figure 17. Analysis of Prospective Dying Cells neighbourhood. 
 
A. Temporal evolution of GFP-Myc levels in NDCs and their neighbour (means). B. 
Temporal evolution of GFP-Myc levels in PDCs and PDC-neighbour means 
synchronized to PDC death. Significant increases between consecutive 100-minute 
sections are shown (arrowheads). C. Temporal evolution of GFP-Myc levels in Myc-Low 
non-dying cells (ML-NDCs), ML-NDC neighbour means and NDCs. D. Temporal 
evolution (locally weighted scatterplot smooth line) of the ratios between GFP-Myc 
levels in NDCs, PDCs, ML-NDCs and their respective neighbour means. E. Temporal 
evolution of Myc-GFP levels in NDCs and PDC neighbour means. F. GFP-Myc levels of 
ML-NDC neighbours synchronised to the initiation of periods in which their mean level 
is equal or higher to that shown by PDC neighbours before PDC death. A-C, E-F 
display SSLs. Pink areas between graph lines in A-C, E indicate p-values <0.01**; 
0.001***; 0.0001****. Statistical analysis in A-C, E were performed by comparing 100-
minute sections between the represented data sets, using a Wilcoxon matched-pairs 
signed rank test for comparing PDCs, NDCs and ML-NDCs with their neighbours and a 
Mann Whitney test for the rest of comparisons. Longitudinal changes of PDCs 
neighbours shown in B were studied using a Mann Whitney test to determine 
significant changes between consecutive 100-minute sections centred at 50-minute 
sliding positions. Transitions between temporal sections showing significant 








5. Random contacts between cells with pre-existing discrepancy in 
Myc levels drive cell competition 
 
Given that the first event anticipating a loser-cell fate is the increase of Myc 
level in its neighbourhood, we decided to study the nature of this increase. The results 
observed could correspond to replacement of neighbours by cells with higher Myc 
levels than their own, or to Myc upregulation in pre-existing neighbours. To analyse 
these options, we inspected individual GFP-Myc profiles of PDC neighbours and 
found that the increase in neighbour’s aggregate GFP-Myc levels normally 
correspond to the presence of only one neighbour at a time with very high GFP-Myc 
levels (Myc-highest neighbours, MHNs) (see examples in Figure 18 A). The total 
number of contacts contributing to the GFP-Myc plateau and the duration of these 
contacts were highly variable (Figure 18 A, B), indicating that MHNs do not engage in 
the interaction with PDCs. When we represented GFP-Myc level temporal profiles 
considering only MHNs we observed similar profiles to those including all neighbours 
(Figure 17 A-C), but with a wider discrepancy in GFP-Myc levels (Figure 18 C-E). In 
addition, we synchronised the complete temporal profile of PDC neighbours to the 
time of their first contact with PDCs and we found that Myc levels in neighbours are 
insensitive to these contacts (Figure 18 F, G). We also found no correlation between 
the frequency of the contacts and the cell cycle phase (Figure 18 B). Moreover, the 
distribution of the duration of PDC contacts with their MHNs was similar to that 
observed with their Myc-low neighbours (Figure 18 H), which indicates that there is 
no specific pattern of direct contacts between prospective winner and loser cells.  
 
These results indicate that it is neighbour exchange and not Myc regulation 
what produces the increase in GFP-Myc levels that precedes cell death (see example 
in video 7); therefore, spontaneous cell competition is driven by apparently random 








6. iMOS-mediated induction of cell competition confirms the 
conclusions from the live analysis of spontaneous cell competition 
 
Our results suggest that Myc-low cell elimination takes place when 
accumulated contacts lead to sustained discrepancies for longer than 600-800 
minutes and is preceded by a progressive decrease of Myc levels in the loser cell.  
 
To test this model, we used the iMOS system (Claveria et al., 2013) to 
experimentally induce cell competition by overexpressing Myc in a mosaic manner 
(see Material and Methods). We performed a time-lapse experiment in which we 
studied the temporal profile of EYFP-Myc cell induction and neighbour death events 
(Figure 19 A-C; video 8, 9; see Material and Methods). In accordance with the 
observations from the live-analysis of spontaneous cell competition, we found an 
increase over 3-fold of the cell death rate at 600 minutes from the onset of EYFP-Myc 
induction (Figure 19 D). Furthermore, when we quantified the death events that were 
not in contact with EYFP-Myc cells, the temporal profile did not exhibit any increase 
 
Figure 18. Dynamics of Myc level regulation and winner-loser interactions. 
 
A. Individual examples of competition, showing the GFP-Myc temporal profile in PDCs 
(red) and PDC-Myc Highest Neighbours (MHNs) (black). Examples show the 
contribution from one to various PDC-MHNs to the increase in GFP-Myc levels in PDC 
neighbours. B. GFP-Myc levels of PDC-MHNs synchronized to cell division (line), 
together with contact periods of PDC-MHN with PDCs (bars, top), and temporal 
profiles of number first contacts and number of tracked cells. C. Temporal evolution of 
GFP-Myc levels in NDCs and their Myc Highest Neighbours (NDC-MHNs). D. 
Temporal evolution of GFP-Myc levels in PDCs and their Myc Highest Neighbours 
(PDC-MHNs). E. Temporal evolution of GFP-Myc levels in ML-NDCs, their Myc 
Highest Neighbours (ML-NDC-MHNs). F. Temporal evolution of mean GFP-Myc levels 
in PDC neighbours synchronized to the time of first contact with a PDC. G. Example of 
the temporal evolution of an individual PDC-MHN in green, sister cell - never in 
contact with the PDC – in blue, mother in red. This example supports the idea that 
MHNs autonomously express Myc and that random contact with PDC trigger the 
elimination of the latest. H. Frequency profile of duration of the periods of contact 
between PDCs and their MHNs and their Myc-L neighbours. A, F, H display locally 
weighted scatterplot smooth lines. B, C-E, G display SSLs. Pink areas between graph 
lines in C-E indicate p-value < 0.0001****. Statistical analysis in C-E were performed 
by comparing 100-minute sections between the represented data sets using Wilcoxon 







in the death rate, which remained linear during the observation time (Figure 19 D). In 
addition, this observation is in accordance with previous works reporting that cell 
competition is cell-to-cell contact dependent (Simpson and Morata, 1981; Moreno et 
al., 2002; Moreno and Basler, 2004; Li and Baker, 2007; Claveria et al., 2013).  
 
 
Figure 19. iMOS-mediated induction of cell competition. 
 
A, B. Confocal images showing the EYFP pattern in iMOST1-Myc ESCs at two time-points 
during the time-lapse after conditional activation. EYFP reveals cells overexpressing 
Myc. Red arrowhead indicates negative cells and white arrowhead indicates EYFP-Myc 
cells. C. Selected frames from live analysis of iMOS-induced cell competition showing 
apoptosis of non-activated cells neighbouring activated iMOST1-Myc cells. D. Cumulative 
temporal representation of EYFP activation events and cell death events in non-EYFP 
cells - in contact or not with iMOST1-Myc cells - after iMOST1-Myc activation. s, slope 
(events/hour). E, F. confocal images showing the EYFP and GFP-Myc patterns in 
iMOST1-Myc / GFP-Myc mixed ESC colonies at two time-points during time-lapse 
analysis after conditional activation. Widespread EYFP reveals cells overexpressing 
Myc and nuclear GFP reveals GFP-Myc cells. White arrowhead indicates EYFP-Myc 
cells, grey arrowheads indicate a PDC and red arrowheads indicate a NDC, both 
neighbours of EYFP-Myc cells. G. Cumulative temporal representation of EYFP 
activation events and GFP-MYC levels in PDC and NDC neighbours of EYFP-Myc cells 
in iMOST1-Myc / GFP-Myc mixed ESC cultures following iMOS induction. D, H display 





Next, in order to study the evolution of GFP-Myc levels in EYFP-Myc cell 
neighbours, we repeated the experiment but co-culturing the iMOST1-Myc cell line with 
the GFP-Myc knock-in line (Figure 19 E-G; video 10). We then identified and traced 
the Myc levels of GFP-Myc cells that were neighbours of EYFP-Myc cells and died 
during the observation period. We found that they showed a sustained decreased in 
their GFP-Myc levels starting shortly after EYFP-Myc induction (Figure 19 H). On the 
contrary, GFP-Myc levels of EYFP-Myc neighbour cells that did not die during the 
tracking were stable during the total period of observation (Figure 19 H). These 
results confirm the conclusions from the live-analysis of spontaneous cell 
competition. 
 
7. The competitive ability of ESCs correlates with Myc levels but not 
with proliferation 
 
We next questioned what was the biological basis of different Myc levels in 
ESC sub-lineages. It has been previously shown that deletion of both Myc and Mycn 
or pharmacological inhibition of Myc activity leads to proliferation arrest by 
decreasing transcription, splicing and protein synthesis (Scognamiglio et al., 2016). 
We then studied the correlation between Myc levels and proliferation and its 
implication in cell competition. The live-imaging analysis allowed us to measure the 
proliferative activity of each cell sub-lineage. We observed that the Myc-Low 
population exhibited a much lower fraction of the population in S-phase than Myc-
High cells (Figure 20 A) and a higher fraction of cells not dividing during tracking 
(Figure 20 B). This means that Myc-L cells proliferate less that the rest of the 
population. In contrast, we found no difference in the proliferative activity between 
Myc-M and Myc-L cell populations (Figure 20 B). Moreover, in cells that divided 
during the period of observation, GFP-Myc levels did no correlate with the frequency 
of mitosis (Figure 20 C).  In addition, we were able to track cell cycle progression by 
synchronizing nuclear sizes to the moment of mitosis. This analysis showed that 
nuclear volume increased linearly during interphase and halved across mitosis 
(Figure 20 D), showing that the increase in nuclear size reports the S-phase of the cell 
cycle.  These observations agree with the extremely short G1 and G2 phases in the 
ESC cycle (Savatier et al., 1994; Boheler, 2009). Study of the temporal profile of 




cell populations (Figure 20 E). These results suggest that Myc levels over a certain 
threshold are required for ESCs to enter the proliferative status, but once in 
proliferation, Myc levels do not determine the cell cycle speed. 
 
Interestingly, both dividing and non-dividing Myc-L cells showed substantially 
increased apoptosis rates (Figure 20 F) meaning that the proliferative status of Myc-L 
cells did not affect their chance to undergo apoptosis. This indicates that ES cells 
compete according to their Myc levels irrespective of their cycling activity.  
 
 
Figure 20. Myc levels and proliferation in ESCs. 
 
A. DNA content cytometry profiles. B. Percentage of dividing and non-dividing cells 
during time-lapse analysis in ESCs classified according to Myc levels. C. Average GFP-
Myc levels in ESCs dividing once or twice during tracking. D. Display of individual 
(dots) and SSL of nuclear size tracking in dividing cells synchronized to cell division 
time (time 0). E. Similar data as in D, in ESCs classified by Myc levels. F. Frequency of 
apoptosis in Myc-L ESCs according to their proliferative behaviour during tracking.  
Boxplots in C show median, 25 and 75 percentiles (boxes), 10 and 90 percentiles 






8. Study of cellular dynamics and Myc levels in ESC colonies 
 
We also used the tracking data to examine several parameters related with cell 
motility and its correlation with GFP-Myc levels. We compared those parameters 
between the Myc-H and Myc-L cell populations. We found no difference between 
both populations in cellular speed, total distance travelled and net displacement 
(Figure 21 A-C). These results indicate that differences in cell motility are not 
involved in the competitive behaviour, supporting the idea of random and passive 
contacts between winners and PDCs.  
 
 
Figure 21. Myc levels and cellular dynamics in ESCs. 
 
A. Measurement of cell speed between Myc-L and Myc-H populations. B. Measurement 
of total displacement between Myc-L and Myc-H populations. C. Measurement of net 
displacement between Myc-L and Myc-H populations. D. Measurement of cell 
roundness between Myc-L and Myc-H populations. E. Measurement of cell roundness 
variation (deformability) between Myc-L and Myc-H populations. Boxplots show 
median, 25 and 75 percentiles (boxes), 10 and 90 percentiles (whiskers). Mann 






We also measured cell roundness and we observed no difference in this 
parameter between Myc-H and Myc-L cells (Figure 21 D). Remarkably, Myc-H cells 
did show higher variance of roundness over time than Myc-L cells (Figure 21 E), 
which indicates higher cell deformability associated with higher Myc levels. 
 
9. Myc expression levels correlate with the pluripotency status  
 
Since we wanted to study the biological origin of Myc-driven endogenous cell 
competition, we next performed a transcriptome analysis of mouse ESCs. We sorted 
three sub-populations of cells according to their Myc levels (Myc-Low, Myc-Medium 
and Myc-High) (Figure 22 A), we extracted RNA of the three sub-populations and 
performed RNAseq. These groups were comparable to those artificially generated in 
the computer workflow for the previous studies (Figure 13 A). After examination of 
the transcriptome, we found that the most significant difference between the 
populations was the regulation of the pluripotency network (Figure 22 B). We then 
decided to compare our transcriptome of ESCs classified by Myc levels with those of 
the naive and primed pluripotent states. We used RNAseq analysis from previous 
works that described these pluripotent states in naive ESCs and epiblast-like cells 
(EpiLCs) (Buecker et al., 2014; Sasaki et al., 2015). EpiLCs are cells in transition 
between naive and primed states that are accomplished in vitro (Hayashi et al., 2011). 
Analysing principal components, we observed that Myc-L cells were closer to 
differentiation-primed EpiLCs, whereas the Myc-H population was more similar to 
naive ESCs and Myc-M cells were located at an intermediate position between both 
states (Figure 22 C). This observation was also supported by the examination of the 
main regulators of pluripotency (Martello and Smith, 2014) (Figure 22 D-E).  The fact 
that the expression profile of the Myc-M population showed an intermediate position 
suggests that Myc levels correlate with changes in the transcriptome that occur in the 
transition from the naive to the primed primed pluripotent state.  
 
Next, we examined whether Myc levels correlated with the activation of the 
two main signalling pathways that characterize the naive and primed pluripotency 
status. We found that in ESCs GFP-Myc levels negatively correlate with pERK 
expression (Figure 23 A, B), whose activation conveys acquisition and maintenance of 




with pSTAT3 activation (Figure 23 C, D), which characterizes and promotes naive 
pluripotency state (Niwa et al., 1998; van Oosten et al., 2012). These observations 
further support that the differentiation status correlates with endogenous Myc levels 
in ESC culture and suggest that differentiation-primed lineages might be 





Furthermore, these data agree with our experimental ESC culture conditions, 
(serum replacement and Leukemia inhibitory factor (LIF) without feeder fibroblasts), 
which allow heterogeneity in the pluripotency status.  
 
 
Figure 22. Transcriptome analysis of GFP-Myc ESCs. 
 
A. Flow cytometry profile of GFP-Myc ESC line showing how populations - Myc-L, 
Myc-M and Myc-H - were established depending on GFP levels. B. Top overlaps 
between gene sets in the GSEA database and the group of genes that change expression 
between Myc-H and Myc-L cells in RNAseq analysis. C. Principal components analysis 
between Myc-H, Myc-M and Myc-L cells, and published expression data reports 
(Buecker et al., 2014; Sasaki et al., 2015) for naive ESCs and epiblast-like stem cells 
(EpiLC). D. Analysis of the genes contributing most to PC1; genes functionally involved 
in pluripotency status regulation or reporting (Guo et al., 2009; Niwa et al., 2009; 
Marks et al., 2012; Ozmadenci et al., 2015; Khoa le et al., 2016; Ye et al., 2016) are 
shown in red. E. Variations between Myc-H and Myc-L ESCs in the amounts of mRNAs 
encoding major regulator of pluripotency status. In blue, the core-pluripotency 
transcription factors; in red, the naive-pluripotency transcription factors; in black, 







10. Myc levels are regulated by the DNA methylation status 
 
DNA methylation (5mC) at CpG dinucleotides is an inhibitory epigenetic 
modification often associated with transcriptional silencing. Other roles of this 
modification in transposable element regulation, splicing and genome integrity have 
also been identified (Smith and Meissner, 2013; Hackett and Surani, 2014). DNA 
methylation mostly faithfully kept through cell divisions, stabilizing restriction of 
cellular identity, except during early development where 5mC is dynamically 
remodeled (Smallwood et al., 2011; Smith et al., 2012; Hackett and Surani, 2014). 
Naive pluripotent cells of the early epiblast show very low levels of methylation 
because of the activity of de-methylating enzymes (TET proteins) and global 
eradication of DNA methylation is needed to eliminate epigenetic barriers against the 
acquisition of naive pluripotency (Hackett et al., 2013).  Previous works have 
reported that naive ESCs show globally hypomethylated DNA when derived in 2i/LIF. 
However, ESCs cultivated in serum exhibit increased levels of DNA methylation 
typically associated with the primed status and further differentiation into specific 
lineages typical of the late epiblast (Hackett and Surani, 2014). In fact, ESCs exhibit 
3-fold higher 5mC in serum in comparison with 2i/LIF culture medium (Ficz et al., 
2013; Habibi et al., 2013; Leitch et al., 2013). Therefore, ES cells maintained in 
2i/LIF conditions show similar levels and distribution of 5mC to the naive epiblast 
cells, whereas cultures grown in serum contains not only naive cells but also cells that 
are closer to primed epiblast cells and show significant DNA methylation. 
 
 
Figure 23. Analysis of the main signalling pathways that characterize the 
naive and primed pluripotency status. 
 
A. Co-localization of pERK and GFP-Myc in ESCs. B. pERK immunofluorescence 
signal in ESCs classified by GFP-Myc levels. C. Co-localization of pSTAT3 and GFP-
Myc in ESCs. D. pSTAT3 immunofluorescence signal in ESCs classified by GFP-Myc 
levels. Dotplots show mean ± 95% confidence interval. Mann Whitney test was used for 






As reflected in our RNAseq analysis, our ESC culture conditions allow 
pluripotency heterogeneity, with some cells closer to naive status and others closer to 
differentiation-primed status, which associates with Myc expression levels. We thus 
tested whether experimental epigenetic modification of the methylation status would 
affect Myc levels. To address this question, we used the drug 5-Azacitidine, which 
 
Figure 24. Analysis of DNA methylation and Myc expression in ESCs. 
 
A. Flow cytometry profile of GFP-Myc ES cells with or without 10 hours of 5-
Azacitidine treatment. B. Flow cytometry profile of GFP-Myc ES cells with or without 
24 hours of 5-Azacitidine treatment, showing the displacement of the curve in the 
experimental condition. C. Flow cytometry profile of GFP-Myc ES cells with or without 
24 hours of 5-Azacitidine treatment plus other additionally 24 hours in normal 
medium, showing the partial recovery of the initial GFP-Myc levels in the experimental 
condition. D. Procedure for confronting control cells (Tomato+) – grown in normal 
medium – and 24-hours treated cells (Tomato-). E. Frequency of Tomato+ and Tomato- 
cell populations after different periods of co-culture. On the left, none of the 







inhibits DNA methyltransferases, causing DNA hypomethylation. We observed that 
Myc levels of GFP-Myc ESCs did not show any variation after 10 hours of treatment 
(Figure 24 A). Notably, ESCs treated with Azacitidine for 24 hours did show an 
increase in their Myc-GFP levels (Figure 24 B; video 11). In addition, we measured 
Myc-GFP levels at 24 hours after treatment removal and observed a partial recovery 
of Myc expression levels in the absence of any treatment (Figure 24 C). These data 
suggest that Myc levels are controlled to a certain extent by DNA methylation and, 
together with the correlation between Myc and the pluripotency status, suggests that 
differentiation-associated methylation is one of the factors that determines the 
heritable modification of Myc levels in ES cell sub-lineages. 
 
Next, we examined whether the increase in Myc levels mediated by 5-
Azacitydine could trigger cell competition. To this end, we cultured GFP-Myc ESCs 
with 0.25 µM 5-Azacitydine for 24 hours and confronted them with membrane-
tomato GFP-Myc ESCs kept in control medium for several days (Figure 24 D). We 
then analysed the proportions of both populations in coculture and found that the 
proportion of the treated cell population –exhibiting higher Myc levels- did no 
increase when confronted with a control cell population (Figure 24 E). This 
observation shows that increasing Myc level by exposure to the demethylating agent 
5-Azacytidine is not sufficient to induce cell competition, suggesting that pleiotropic 
effects of the drug abrogate ESC competitive ability. 
 
11. 2i culture conditions reduce Myc heterogeneity and blocks 
endogenous cell competition  
 
As previously shown, our experimental ESC culture conditions allow 
heterogeneity in pluripotency status. In addition, since LIF limits the transition from 
naive to primed pluripotent states and the primed state is not reversible by changes 
in the signalling environment (Guo et al., 2009), our observations are also in 





Previous work reported that ESCs cultured with MAPK and GSK inhibitors (2i) 
maintain the naive state, giving rise to cultures expressing pluripotency markers in a 
more homogeneous manner (Ying et al., 2008). As we showed that cell competition 
takes place when cells with discrepant Myc levels are confronted and these levels 
correlate with the pluripotency status, we examined the effect of 2i culture conditions 
on Myc expression and the competitive behaviour of ESCs. To address this question, 
 
Figure 25. Study of 2i culture condition effects on Myc expression and cell 
competition in ESCs. 
 
A. Coefficient of variation (heterogeneity) of GFP-Myc levels in SR+LIF medium and in 
2i+LIF medium. B. Relative frequency of caspase-3 positive cells in SR+LIF and in 
2i+LIF. C. GFP-Myc levels in non-apoptotic (general population) and apoptotic 
(caspase-3 positive) cells in SR+LIF. D. GFP-Myc levels in non-apoptotic (general 
population) and apoptotic (caspase-3 positive) cells in 2i+LIF. Boxplot in A, C and D 
show median, 25 and 75 percentiles (boxes), 10 and 90 percentiles (whiskers). Column 
bar graph in B show mean and standard error of the mean (SEM). Mann Whitney test 






we cultured GFP-Myc ES cells with or without 2i for three days. We found that Myc 
level heterogeneity was reduced in 2i conditions (Figure 25 A). Next, we studied 
whether the decrease in Myc heterogeneity led to a change in the competitive ability 
by measuring the frequency of apoptotic events and Myc levels of those apoptotic 
cells. Interestingly, the death frequency was 3-fold less in the 2i conditions with 
respect to serum+LIF culture conditions (Figure 25 B).  We then measured Myc levels 
in non-apoptotic cells and in dying cells in the first phases of apoptosis, when they 
present active caspase-3 staining but still intact nuclei. As expected (Claveria et al., 
2013), in serum replacement+LIF culture conditions Myc levels were higher in non-
apoptotic cells than in early apoptotic cells (Figure 25 C). However, in 2i culture 
conditions there was no significant difference in Myc levels between apoptotic and 
non-apoptotic cells (Figure 25 D). These results show that, in similarity to the core 
pluripotency factors, Myc expression heterogeneity is reduced in ESCs cultured in 2i 
conditions, which further supports the idea of the correlation between Myc and the 
pluripotency status. Moreover, Myc-mediated spontaneous cell competition does not 
take place in naive ESC cultures where discrepancies in Myc levels between cells are 
reduced. 
 
12. Cell competition can be experimentally induced by confronting 
cells with different pluripotency status 
 
We showed in previous experiments that differentiation-primed cells might be 
eliminated by their naive neighbours.  To directly test this hypothesis, we induced ES 
cells to differentiate by LIF withdrawal and confronted them with naive ES cells kept 
in LIF, plus 2i (Figure 26 A). We analysed the proportions of both populations over 
time and found that the differentiating ESC population was outcompeted by naive ES 
cells (Figure 26 B). These differentiating ES cells were otherwise viable when cultured 
alone, but the frequency of apoptosis increased almost 3-fold when co-cultured with 
naive cells (Figure 26 C), indicating that the elimination of the differentiating 
population occurs through cell competition. Moreover, in agreement with previous 
studies (Sumi et al., 2007) and our RNAseq analysis, the differentiating population 
exhibited lower GFP-Myc levels than the naive population in co-culture (Figure 26 D, 
E), which confirmed the expected correlation between Myc levels and competitive 




pluripotency in ESCs and that the confrontation of Myc-high naive cells with My-low 




Figure 26. Cell competition induced by confronting population with 
different pluripotency status. 
 
A. Procedure for confronting differentiating ESCs (Tomato+) and naive ESCs (Tomato-
). B. Frequency of Tomato+ and Tomato- cell populations after different periods of co-
culture. C. Frequency of caspase3-positive cells in the differentiating Tomato+ cell 
population alone or in co-culture with naive ESCs. Data were collected by microscopic 
fields (N). D. Immunofluorescence study of Myc levels after 2-day co-culture of 
Tomato- ESCs pre-cultured for 3 days with LIF+2i and Tomato+ ESCs pre-cultured for 
3 days without LIF. E. GFP-Myc levels in Tomato+ and Tomato- cell populations in co-
culture. Column bar graph in C show mean and standard error of the mean (SEM). 
Boxplot in E show median, 25 and 75 percentiles (boxes), 10 and 90 percentiles 






13. Blocking cell competition results in the accumulation of 
differentiation-primed cells 
 
We next explored whether cell competition could be acting as a mechanism to 
prevent the accumulation of cells that are prone to differentiate in ESC cultures. To 
address this question we used the iMOST1-p35 ESC line (Claveria et al., 2013), in which 
following tamoxifen addition, a mosaic of EYFP- and ECFP-expressing cells is 
induced and apoptosis is inhibited in the ECFP population because of the expression 
of the caspase inhibitor p35, whereas the EYFP population remains WT and is 
allowed to undergo apoptosis (Figure 27 A). ECFP protein was not well detected in 
the microscope, therefore we recognize ECFP positive cells by doing immunostaining 
with anti-GFP antibodies, which recognize both ECFP and EYFP, so that cells positive 
for anti-GFP staining and negative for EYFP were identify as ECFP p35-expressing 
cells (Figure 27 B).    
 
We then compared the death-blocked population 48 hours after the induction 
(see Material and Methods) with the wild type neighbours and found that the rescued 
cells showed a higher proportion of active-pERK levels than the control population 
(Figure 27 B, C). This result suggests that cell competition might be acting in 






14. Differentiating-primed cells are eliminated from pre-
gastrulation embryos through cell competition  
 
14.1. Myc/pERK regulation in the epiblast  
 
We then studied whether this observed mechanism applies to epiblast cells in 
the early mouse embryo. To this end, we first examined the pattern of pERK 
activation in early postimplantation embryos. We found that at E5.0 the epiblast did 
not contain any pERK positive cell (Figure 28 A). In contrast, E6.0 embryos showed 
around 1-4% of isolated cells positive for pERK in an apparently random pattern 
(Figure 28 B-D). This pERK positive cell population exhibited lower Myc levels than 
the pERK negative cells (Figure 28 C, D), suggesting a similar relationship in vivo as 
that found in ESCs.  
 
Next, we studied the pattern of pERK expression in early gastrulating embryos. 
The embryo gastrulates by the recruitment of epiblast cells to the primitive streak. 
During this process, a coordinated loss of pluripotency occurs in the vicinity of the 
primitive streak for mesoderm formation.  At this embryonic stage, we found a 
regional expression of pERK and downregulation of Myc close to the primitive streak 
region (Figure 28 E). These results suggest that Myc/pERK regulation in the epiblast 
correlates with the patterns found in ESC cultures.  
 
Figure 27. Cell competition and pluripotency status studied by cell death 
inhibition using the iMOST2-p35 mosaic approach in ESCs. 
 
A. Scheme showing the iMOS strategy for inhibiting cell competition in ESCs. B. Co-
localization of direct detection of EYFP with immunofluorescent detection of total 
fluorescent protein (FP) and active pERK. Arrowhead indicates an ECFP-p35+ cell, 
identified by absence of EYFP and presence of FP immunodetection. Asterisk indicates 
FP-negative cells. C. Active-pERK levels fold change in ECFP-p35+ cells vs 
neighbouring wild type cells. Boxplot show median, 25 and 75 percentiles (boxes), 10 









Figure 28. Analysis of pERK activation in the epiblast and correlation with 
Myc levels. 
 
A. Confocal detection (optical sections) of pERK immunofluorescence in an E5.0 
mouse embryo showing no pERK+ cells in the epiblast. B. Confocal detection (optical 
sections) of pERK immunofluorescence in an E6.0 mouse embryo. White arrowheads 
show pERK+ cells. C. Co-localization by immunofluorescence of Myc and active pERK 
in the epiblast of E6.0 mouse embryos. White arrowhead shows a pERK+ cell exhibiting 
low GFP-Myc levels. D. Scoring of detected active pERK+ cells in the E6 mouse epiblast. 
E. Normalized Myc level distributions in active pERK+ and pERK- cells of the mouse E6 
epiblast. F. Co-localization by immunofluorescence of Myc and active pERK in the 
epiblast of E6 and E6.5 mouse embryos. EE, extraembryonic; Epi, Epiblast; PS, 
primitive streak. Boxplot in E shows median, 25 and 75 percentiles (boxes), 10 and 90 






14.2. pERK positive cells are accumulated when blocking apoptosis 
in early embryos 
 
We next studied whether the population of isolated pERK+ cells is restricted 
by cell competition in the pre-gastrulation embryo, as it does in ESC cultures. To 
address this question, we used the iMOS system to induce mosaics of p35-expressing 
cells and WT cells in embryos. We analyzed embryos at E5.5-6 where pERK-activated 
cells were scarcely present in the wild type population (Figure 29 A). Interestingly, we 
observed that pERK positive cells specifically accumulated in the death-blocked p35-
expressing population (Figure 29 B, C). This observation suggests that 




Figure 29. Cell competition inhibition and pluripotency status analysed 
using the iMOST2-p35 mosaic approach in the epiblast. 
 
A. Co-localization of EYFP and active pERK+ cells in the epiblast of E5.5 iMOST2p35 
mouse embryos recombined with Sox2Cre. B. Scoring of detected pERK+ cells in the 
epiblast of E5.5 iMOST2-p35 embryos recombined with Sox2Cre. C. Frequency of EYFP-
WT and ECFP-WT cells in the 10 embryos. Boxplot in C show median, 25 and 75 
percentiles (boxes), 10 and 90 percentiles (whiskers). Mann Whitney test was used for 





15. Myc directly defines the ESC competitive ability irrespective of 
the pluripotency status 
 
We next studied the functional relationship between Myc and the pluripotency 
status. To this end we used the iMOST1-Myc cell line, in which we induced Myc 
overexpression in a random subset of cells cells (Figure 30 A). This iMOS mediated 
Myc overexpression is enough to induce cell competition as it has been described 
(Claveria et al., 2013) and we showed above (Figure 19). We found that after Myc-
overexpressing cells in mosaic cultures did not decrease pERK levels in comparison 
to their WT neighbors; in fact, they underwent a slight increase (Figure 30 A, B). 
 
In addition, a compared transcriptome analysis by RNAseq between EYFP-
Myc and control populations from mosaic cultures (C. Clavería, unpublished) not 
only did not show promotion of the naive pluripotency signature but rather a mild 
inhibition of this (Figure 30 C). Conversely, ESC differentiation by LIF withdrawal 
leads to GFP-Myc downregulation (Figure 26 D, E), in agreement with previous 





These results, together with the induction of the winner phenotype by the Myc 
induction (Claveria et al., 2013), suggest a linear pathway in which Myc lies 
downstream the differentiation status and Myc directly determines the competitive 




















Figure 30. Study of the functional relationship between Myc and the 
pluripotency status. 
 
A. Co-localization of active pERK and Myc in ESCs with mosaic overexpression of 
EYFP-Myc from the iMOST1-Myc allele. B. Distributions of active-pERK levels in WT 
ESCs and ESCs overexpressing EYFP-Myc from the iMOST1-Myc allele. C. Variations 
between WT and EYFP-Myc overexpressing cells in the amounts of mRNAs encoding 
major regulators of pluripotency status. In blue, the core-pluripotency transcription 
factors; in red, the naive-pluripotency transcription factors; in black, Fgf5, a marker of 
primed pluripotency. Boxplot in B show median, 25 and 75 percentiles (boxes), 10 and 
90 percentiles (whiskers). For statistics Mann Whitney test was used. ns, adjusted p-



























In this doctoral thesis we have studied how Myc is regulated and how its 
heterogeneous expression and dynamics leads to spontaneous cell competition in 
ESCs. Additionally, we have explored the biological relevance of Myc-dependent 
endogenous cell competition both in ESCs and in early mouse development. 
 
Despite the key role reported for both Myc and Mycn during embryogenesis 
(Charron et al., 1992; Trumpp et al., 2001; Dubois et al., 2008) and their redundant 
and cooperative function in maintaining the ESC proliferative program (Malynn et 
al., 2000; Scognamiglio et al., 2016), we showed that Mycn expression does not 
correlate with Myc expression in ESCs and, contrary to observations with Myc 
(Claveria et al., 2013), that endogenous Mycn levels do not correlate with the 
winner/loser ESC status. These observations, together with the absence of Mycl in 
ESCs, indicate that Myc regulation is the main driver of spontaneous cell competition 
in ESCs, with no contribution from other members of the proto-oncogene Myc family.  
 
Given the major role of Myc in cell competition in ESCs, in this thesis we have 
developed new time-lapse microscopy and image analysis tools to track Myc levels 
during cell competition. To this end, we used an ESC line expressing a GFP-Myc 
fusion protein that faithfully reports endogenous Myc levels. To our knowledge, this 
new developed technique for tracking ESC lineages and endogenous Myc levels in 
3D+t is the first described in the field of study. In a recently published work ESCs are 
tracked in 2D in conditions in which cell-to-cell interactions are inhibited and 
therefore it is not suitable for cell-interactive studies (Filipczyk et al., 2015). Our 
methodology allowed us to track ESC lineages through cell division and under 
entirely interactive conditions.  
 
Furthermore, cell competition in ESCs and in the mouse epiblast is regulated 
by Myc expression heterogeneity among cells, however due to the lack of a strategy 
for isolating and tracking live cells according to Myc levels, the biological basis of 
Myc-low cells outcompetition from ESC cultures and early embryos was unknown. In 
this thesis, these limitations have been overcome by implementing this new 
microscopy and image analysis tool. Moreover, we also tracked the temporal 
evolution of Myc levels during cell proliferation, which has never been reported in 




information on the history of Myc levels for each cell, together with 3D information 
that allows to determine neighbourhood relationships between cells. 
 
Using this tool we studied the stability of Myc levels in different 
subpopulations defined by Myc levels, both during the observation period and 
through cell divisions. We showed that Myc expression levels in ESCs are imprinted 
to a large extent, such they are conserved trough mitosis. Additionally, retrospective 
clonal analysis experiments suggest that Myc levels display high heritability (0.8 per 
cell division). These data allow the emergence of a new concept that we called 
heritable fitness and consists on the heritable competitive ability of cells based on the 
transmission of Myc levels in ESCs sublineages coexisting in culture. The concept of 
Myc heritability is different from previous knowledge on the main factors 
contributing to Myc regulation. While Myc is generally found to be regulated by 
extracellular signals in somatic cells (Wierstra and Alves, 2008), both the cell-to-cell 
heterogeneous pattern and the heritability of MYC expression levels in ESCs indicate 
an important contribution of cell-intrinsic heritable features, in Myc regulation in ES 
cells. 
 
The computer workflow established also allowed us to track Myc expression 
levels in individual cells and its neighbours, which allows the study of the dynamics of 
endogenous cell competition in a quantitative manner. Using this methodology, we 
have demonstrated that cell competition is driven by random contacts between cells 
with high discrepancies in Myc levels. Low-Myc cells are thus able to survive in ESC 
colonies as long as the differences in Myc expression levels between them and their 
neighbours are moderate or transient, however sustained discrepancies for longer 
than 600-800 leads to the elimination of the loser cells.  We observed that the Myc 
expression profile during the 600-800 minutes preceding death of the loser shows a 
plateau shape.  This observation indicates that loser cells measure time in exposure to 
neighbours with a discrepancy in Myc levels above a certain threshold, rather than 
accumulated Myc discrepancy. In case loser cells were measuring accumulated Myc 
discrepancies, then shorter exposures to higher Myc levels would also lead to cell 
competition and the shape of the Myc expression profile in neighbour of loser cells 





Nevertheless, as the computer workflow only tracks and measures Myc levels 
of neighbour cells whose membranes are in direct contact with those of the loser cells, 
we only explored cell-to-cell contact dependent cell competition. Our initial 
hypothesis agrees with previous work reporting that direct contact is needed for 
competitive interactions (Simpson and Morata, 1981; Moreno et al., 2002; Moreno 
and Basler, 2004; Li and Baker, 2007; Claveria et al., 2013). Furthermore, since in 
our induced cell competition time-lapse experiments cell death rate is only increased 
in the population in direct contact with EYFP-Myc overexpressing cells, we obtained 
here further evidence of the need for cell-to-cell contact to induce apoptosis of loser 
cells.  
 
We also observed, both in endogenous and in induced cell competition, a 
tendency in PDCs to reduce their Myc levels approximately 500 minutes before death 
and just after the increase in their neighbours’ Myc expression levels. The nature of 
this decrease is not known yet; however, in our time-lapse analyses using a caspase-3 
reporter, we observed that caspase-3 is activated only few minutes before the cell 
death suggesting that Myc reduction in PDCs is not due to the activation of caspase-
apoptotic pathway. Thus, competitive interactions might be operating on pathways 
triggering Myc downregulation for extended periods in loser cells. 
 
Our analysis shows that in ESC cultures Myc-low cells are continuously 
eliminated and replaced by Myc-high cells. If this process were continuous, after 
cultures would continuously evolve towards higher and more homogeneous Myc 
levels; nevertheless, ESCs cultures always exhibit heterogeneous levels of Myc.  Thus, 
we hypothesize that continuous and spontaneous generation of low-Myc cells and 
their elimination by fitter cells should maintain the equilibrium between ESC 
populations with different Myc levels in ESC colonies. 
 
We also explored the different roles and dynamics of loser and winner cells 
during cell competition. On one hand, previous works have shown the involvement of 
increased cell mixing activity of winner cells in Myc-induced cell competition in 
Drosophila imaginal discs (Levayer et al., 2015), which contrast with our 
observations of any obvious active role of either winner or loser cells. In our model, 




contacts. Nevertheless, Drosophila imaginal discs cells are organized in a columnar 
epithelium where different sublineages mix poorly, whereas in ESC cultures there is a 
constitutive intense mixing, suggesting that the different environments may explain 
the differences observed between these two models. 
 
On the other hand, we observed that Myc-high cells show higher variance of 
roundness over time that Myc-low cells. This result agrees with previous works in 
mammalian cells in which the winner phenotype presents higher deformability 
mediated by RhoA and actomyosin (Sun et al., 2014b). In addition, engulfment of 
losers by winner cells, which may involve differences in cytoskeleton dynamics, was 
also observed in mouse ESC and epiblast cells (Claveria et al., 2013) .  Engulfment 
was also reported to be the main system to eliminate loser cells in the Drosophila (Li 
and Baker, 2007); nonetheless, this observation contrasts with other recent works 
also performed in this model  (Levayer et al., 2015).  
 
Transcriptome analysis and the subsequent study of the main pathways 
characterizing naive and primed states allowed us to correlate Myc expression levels 
with the pluripotency status. A pool of pluripotent cells is maintained in early 
mammalian embryos for several days, however pluripotency is a highly unstable 
state, suggesting that specific mechanisms should be in place for pluripotency 
maintenance during this period. In this thesis we described a mechanism in which 
differentiation-primed cells are eliminated due to discrepancies in Myc levels with 
surrounding naive pluripotent cells. The fact that differences in pluripotency status 
may drive cell competition agrees with previous works reporting outcompetition of 
BMP-receptor-defective cells from ESC cultures and mouse epiblast (Sancho et al., 
2013). BMP signalling collaborates with STAT3 in maintaining the naive pluripotency 
status, and therefore BMP receptor mutants may not be able to maintain the naive 
pluripotent status, leading to Myc downregulation and cell competition. 
 
However, since not all Myc-low cells show differentiation-primed signatures, 
the difference in the pluripotent status may only explain part of the Myc-low 
population. Therefore, it would be important to identify additional cellular features 
characteristic of the Myc-low population to achieve a fully characterization of 




phenomenon of cell competition during one phase of the development and this 
mechanism could be also playing a role in other stages of the early mouse embryo. In 
fact, previous works already reported apoptosis in the inner cell mass of the 
blastocyst (Plusa et al., 2008), much before the stage in which this thesis is focused. 
At that stage the primitive endoderm differentiates and segregates from the inner cell 
mas of the blastocysts, which is the second event of differentiation after 
trophectoderm differentiation (Stephenson et al., 2012).  In a first step, primitive 
endoderm cell specification takes place in a spatially disorganized manner within the 
inner cell mass, so that cells of the PE lineage and those of the epiblast are 
intermingled.  In a second step, cells specified as primitive endoderm segregate 
towards the blastocoel lumen.  Interestingly, cells specified as primitive endoderm 
that fail to segregate from the pool of pluripotent cells of the inner cells enter in 
apoptosis (Plusa et al., 2008; Stephenson et al., 2012). Moreover, Myc levels are 
heterogeneously expressed also in the inner cell mass of blastocyst (Claveria et al., 
2013) and is downregulated when cells differentiate to primitive endoderm (Smith et 
al., 2010). All these observations suggest that Myc-driven cell competition triggered 
by discrepant differentiation status may not only occur in the context described here, 
but may function as a more general mechanism affecting other developmental stages. 
 
Additionally, recent work reports an apoptosis-dependent selection process 
during the colonization of the blastocyst inner cell mass by injected ESCs.  In this 
model, naive ESCs preferentially colonize the inner cell mass, while primed ESCs are 
preferentially eliminated from the embryo by apoptosis (Alexandrova et al., 2016). 
This observation agrees with the model described here, however, in this work, ESC 
elimination does not correlate with Myc levels in the inner cell mass cells, which 







Figure 31. Proposed model of Myc-driven cell competition protecting 
pluripotent cells against differentiation in ESCs and epiblast. 
 
In ESCs differentiation-primed Myc-low cells are continuously outcompeted and 
replaced by naive Myc-high cells. However, there is a spontaneous generation of these 
primed low-Myc cells that maintains equilibrium in ESC colonies. 
In the embryo cell competition is preserving the naive pluripotent status of the epiblast 
by eliminating cells in transit to differentiation before the time is right for 
differentiation. In contrast, when epiblast gastrulates a coordinated differentiation 
occurs in the posterior part of the epiblast and Myc is simultaneously downregulated, 






Myc has a role during induced pluripotent stem cell generation in promoting 
cell reprogramming of somatic cells in cooperation with transcription factors of the 
core pluripotency network (Takahashi and Yamanaka, 2006); in this thesis we 
described a mechanism that could help to better understand Myc implication in this 
process. First, we show that enhanced Myc activity does not promote the naive 
pluripotency signature, which fits results from other studies (Kim et al., 2010; Gu et 
al., 2016; Scognamiglio et al., 2016). Second, we observe that pluripotent cell 
proliferation can be efficiently driven by low Myc activity suggesting that Myc 
expression levels would be hardly relevant for stimulating proliferation during 
reprogramming. Indeed it has been reported that reprogramming of somatic cells can 
take place at lower efficiency in the absence of Myc overexpression (Nakagawa et al., 
2008), which is compatible with our findings suggesting Myc’s role in 
reprogramming relates to promotion of pluripotent cell selection rather than to direct 
stimulation of pluripotency or proliferation. 
 
Taken altogether, we propose a model in which cell competition maintains the 
naive pluripotency status in mouse pluripotent stem cell populations by eliminating 
cells in transit to differentiation (Figure 31). We provide evidence of a linear pathway 
in which Myc levels are determined by the pluripotency status and set ESC 
competitive ability without affecting the pluripotency status. This mechanism 
provides protection of naive pluripotent cell pools from premature differentiation by 
eliminating differentiation-prone cells; therefore cell competition operates as a 
surveillance mechanism of the stem cell pools in the mouse epiblast and ESC groups. 
When isolated cells spontaneously start to differentiate in a context of predominant 
naive cells, the contrast in Myc levels between the differentiating cell and its 
neighbours induces their elimination. In the early epiblast, this mechanism controls 
the naive status of the epiblast cell pool before the time is right for differentiation. In 
contrast, when the embryo starts to gastrulate, coordinated differentiation occurs and 
Myc levels and differentiation priming are homogeneously regulated in the posterior 
area of the epiblast. We therefore hypothesize that at this stage, the homogenous 
decrease in Myc levels avoids differences between cells and programed differentiation 


























1.  Myc regulation is the main driver of spontaneous cell competition in ESCs, 
with no involvement of other members of the Myc family. 
 
2.  The GFP-Myc knock-in line faithfully reports endogenous Myc levels and 
the imaging tool established provides a complete and reliable set of biological data 
during Myc-dependent cell competition in ESCs. 
 
3.  Myc expression levels are depleted by specific degradation of the Myc 
protein during ESC mitosis. 
 
4.  Myc levels are largely imprinted in ESCs, being mostly regulated by cell-
intrinsic heritable factors. 
 
5.  Passive contacts between cells with high discrepancies in Myc levels that 
extend longer than ~10 h trigger cell competition in ESCs. 
 
6.  The proliferative state of ESCs requires Myc levels over a certain threshold, 
however, Myc levels do not modulate the speed of proliferation in cycling ESCs. The 
competitive ability of ESCs is dictated by Myc levels irrespective of the proliferation 
rate. 
 
7.  Myc levels correlate with the differentiation status and are controlled by 
epigenetic control in ESCs. 
 
8.  Endogenous cell competition maintains the naive pluripotent status of ESC 
cultures by eliminating differentiating cells. 
 
9.  Myc lies downstream the differentiation status and directly determines the 
ESC competitive ability. 
 
10.   Myc-driven cell competition triggered by discrepant pluripotency 
status also occurs in vivo, where differentiation-primed cells are eliminated from the 
pre-gastrulation epiblast. 





1.   La regulación de Myc es el principal factor desencadenante de la 
competición celular espontánea en CMEs, sin implicación de otros miembros de la 
familia de genes Myc. 
 
2.  La línea de ratón knock-in GFP-Myc reporta fehacientemente los niveles de 
expresión endógenos de Myc y la herramienta de imagen desarrollada proporciona 
un completo y fiable conjunto de datos biológicos durante la competición celular 
dependiente de Myc en CMEs. 
 
3.  Los niveles de expresión de Myc disminuyen por degradación específica de 
la proteína Myc durante la mitosis en CMEs. 
 
4.  Los niveles de Myc son en gran parte “grabados” en CMEs, siendo en 
general regulados por factores heredables intrínsecos. 
 
5.  En CMEs la competición celular se desencadena por contactos pasivos entre 
células con grandes discrepancias en sus niveles d Myc que se extienden más de ~ 10 
horas. 
 
6.  El estado proliferativo de las CMEs requiere unos niveles de Myc por 
encima de un cierto umbral, sin embargo, éstos no modulan la velocidad de 
proliferación de células en mitosis. La capacidad competitiva de las CMEs está 
determinada por los niveles de Myc independientemente de la tasa de proliferación. 
 
7.  Los niveles de Myc correlacionan con el estado de diferenciación y son 
controlados mediante regulación epigenética en CMEs. 
 
8.  La competición celular endógena mantiene el estado de indiferenciación de 
los cultivos de CMEs mediante la eliminación de células en proceso de diferenciación. 
 
9.  Myc se encuentra por debajo del estado de diferenciación y determina 





10.   La competición celular dependiente de Myc y desencadenada por 
diferencias en el estado de pluripotencia también tiene lugar in vivo, donde las 
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